CHEBI ONTOLOGY - ANNOTATIONS |
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
Term: | thimerosal |
|
Accession: | CHEBI:9546
|
browse the term
|
Definition: | An alkylmercury compound (approximately 49% mercury by weight) used as an antiseptic and antifungal agent. |
Synonyms: | exact_synonym: | sodium [(2-carboxylatophenyl)sulfanyl](ethyl)mercurate(1-); sodium ethyl[2-(sulfanyl-kappaS)benzoato(2-)]mercurate(1-) |
| related_synonym: | Formula=C9H9HgNaO2S; Formula=C9H9HgO2S.Na; InChI=1S/C7H6O2S.C2H5.Hg.Na/c8-7(9)5-3-1-2-4-6(5)10;1-2;;/h1-4,10H,(H,8,9);1H2,2H3;;/q;;2*+1/p-2; InChIKey=RTKIYNMVFMVABJ-UHFFFAOYSA-L; Merthiolate; SMILES=[Na+].CC[Hg]Sc1ccccc1C([O-])=O; Thiomersal; [(o-carboxyphenyl)thio]ethylmercury sodium salt; ethyl(2-mercaptobenzoato-S)mercury sodium salt; ethylmercurithiosalicylate sodium; ethylmercurithiosalicylic acid sodium salt; mercurothiolate; o-(ethylmercurithio)benzoic acid sodium salt; sodium merthiolate; thiomersalate; thiomersalum; tiomersal |
| xref: | CAS:54-64-8; Gmelin:1677155; KEGG:D00864 |
| xref_mesh: | MESH:D013849 |
| xref: | PMID:18837732; PMID:21616561; PMID:21785120; PMID:22015977; PMID:22366633; PMID:22658806; PMID:22811707; PMID:23145070; PMID:23223227; PMID:23282150; PMID:23401210; PMID:23554557; PMID:23843785; PMID:23949514; PMID:23965928; PMID:23992327; PMID:25042713; PPDB:3062; Reaxys:8169555; VSDB:3062 |
|
|
|
G |
Abhd17b |
abhydrolase domain containing 17B, depalmitoylase |
increases expression |
ISO |
Thimerosal results in increased expression of ABHD17B mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:219,198,294...219,232,733
Ensembl chr 1:219,198,471...219,231,933
|
|
G |
Abtb3 |
ankyrin repeat and BTB domain containing 3 |
multiple interactions |
ISO |
[NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ABTB3 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 7:18,035,151...18,310,718
Ensembl chr 7:18,036,083...18,310,834
|
|
G |
Acacb |
acetyl-CoA carboxylase beta |
decreases expression |
ISO |
Thimerosal results in decreased expression of ACACB mRNA |
CTD |
PMID:27188386 |
|
NCBI chr12:42,365,800...42,477,651
Ensembl chr12:42,366,548...42,457,655
|
|
G |
Acsl4 |
acyl-CoA synthetase long-chain family member 4 |
increases expression |
ISO |
Thimerosal results in increased expression of ACSL4 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr X:105,942,794...106,006,573
Ensembl chr X:105,942,799...106,006,427
|
|
G |
Actmap |
actin maturation protease |
decreases expression |
ISO |
Thimerosal results in decreased expression of ACTMAP mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:82,490,313...82,499,841
Ensembl chr 1:82,490,363...82,499,841
|
|
G |
Actr2 |
actin related protein 2 |
decreases expression |
ISO |
Thimerosal results in decreased expression of ACTR2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr14:94,296,443...94,333,735
Ensembl chr14:94,296,443...94,340,524
|
|
G |
Adcy7 |
adenylate cyclase 7 |
decreases expression |
ISO |
Thimerosal results in decreased expression of ADCY7 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr19:18,740,875...18,798,924
Ensembl chr19:18,740,875...18,776,311
|
|
G |
Adgrb2 |
adhesion G protein-coupled receptor B2 |
decreases expression |
ISO |
Thimerosal results in decreased expression of ADGRB2 mRNA |
CTD |
PMID:24675092 |
|
NCBI chr 5:142,299,190...142,362,540
Ensembl chr 5:142,331,329...142,362,540
|
|
G |
Adgrl3 |
adhesion G protein-coupled receptor L3 |
increases expression |
ISO |
Thimerosal results in increased expression of ADGRL3 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr14:26,336,320...27,104,060
Ensembl chr14:26,368,277...27,105,860
|
|
G |
Adgrv1 |
adhesion G protein-coupled receptor V1 |
increases expression |
ISO |
Thimerosal results in increased expression of ADGRV1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 2:11,331,434...11,911,713
Ensembl chr 2:11,331,442...11,911,688
|
|
G |
Adm |
adrenomedullin |
decreases expression |
ISO |
Thimerosal results in decreased expression of ADM mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:164,745,466...164,747,654
|
|
G |
Adss1 |
adenylosuccinate synthase 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of ADSS1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 6:131,679,795...131,702,012
Ensembl chr 6:131,679,701...131,701,998
|
|
G |
Afap1l1 |
actin filament associated protein 1-like 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of AFAP1L1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr18:55,183,786...55,244,174
Ensembl chr18:55,183,786...55,244,146
|
|
G |
Aff4 |
ALF transcription elongation factor 4 |
decreases expression |
ISO |
Thimerosal results in decreased expression of AFF4 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr10:37,498,825...37,579,751
Ensembl chr10:37,498,825...37,579,751
|
|
G |
Agbl5 |
AGBL carboxypeptidase 5 |
decreases expression |
ISO |
Thimerosal results in decreased expression of AGBL5 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 6:25,472,333...25,492,173
Ensembl chr 6:25,472,333...25,490,738
|
|
G |
Agfg1 |
ArfGAP with FG repeats 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of AGFG1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 9:84,124,845...84,182,615
Ensembl chr 9:84,125,120...84,178,128
|
|
G |
Ago1 |
argonaute RISC component 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of AGO1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 5:138,722,111...138,757,118
Ensembl chr 5:138,722,111...138,773,546
|
|
G |
Agpat1 |
1-acylglycerol-3-phosphate O-acyltransferase 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of AGPAT1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr20:4,135,955...4,144,880
Ensembl chr20:4,135,957...4,145,278
|
|
G |
Ahcy |
adenosylhomocysteinase |
decreases expression |
ISO |
Thimerosal results in decreased expression of AHCY mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 3:143,569,134...143,584,359
Ensembl chr 3:143,569,094...143,584,393
|
|
G |
Ahnak2 |
AHNAK nucleoprotein 2 |
decreases expression |
ISO |
Thimerosal results in decreased expression of AHNAK2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 6:131,830,668...131,876,311
|
|
G |
Aifm1 |
apoptosis inducing factor, mitochondria associated 1 |
increases secretion |
ISO |
Thimerosal results in increased secretion of AIFM1 protein |
CTD |
PMID:12140745 |
|
NCBI chr X:127,650,223...127,689,356
Ensembl chr X:127,650,226...127,689,256
|
|
G |
Ak4 |
adenylate kinase 4 |
decreases expression |
ISO |
Thimerosal results in decreased expression of AK4 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 5:116,039,222...116,099,064
Ensembl chr 5:116,039,616...116,098,618
|
|
G |
Akap11 |
A-kinase anchoring protein 11 |
increases expression |
ISO |
Thimerosal results in increased expression of AKAP11 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr15:53,911,635...53,956,138
Ensembl chr15:53,911,657...53,941,605
|
|
G |
Akap8l |
A-kinase anchoring protein 8 like |
increases expression |
ISO |
Thimerosal results in increased expression of AKAP8L mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 7:11,332,671...11,362,287
Ensembl chr 7:11,332,672...11,362,275
|
|
G |
Akap9 |
A-kinase anchoring protein 9 |
increases expression |
ISO |
Thimerosal results in increased expression of AKAP9 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 4:30,056,738...30,192,716
Ensembl chr 4:30,056,738...30,192,606
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions decreases phosphorylation |
ISO |
Thimerosal promotes the reaction [wortmannin results in decreased phosphorylation of AKT1 protein]; wortmannin promotes the reaction [Thimerosal results in decreased phosphorylation of AKT1 protein] |
CTD |
PMID:23145070 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Akt3 |
AKT serine/threonine kinase 3 |
decreases expression |
ISO |
Thimerosal results in decreased expression of AKT3 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr13:88,943,708...89,225,831
Ensembl chr13:88,946,091...89,225,708
|
|
G |
Alas1 |
5'-aminolevulinate synthase 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of ALAS1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 8:106,876,514...106,889,917
Ensembl chr 8:106,876,514...106,889,917
|
|
G |
Alb |
albumin |
affects binding |
ISO |
Thimerosal binds to ALB protein |
CTD |
PMID:18197631 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Aldh3a2 |
aldehyde dehydrogenase 3 family, member A2 |
decreases expression |
ISO |
Thimerosal results in decreased expression of ALDH3A2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr10:45,928,313...45,949,366
Ensembl chr10:45,908,524...45,949,281
|
|
G |
Aldh5a1 |
aldehyde dehydrogenase 5 family, member A1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of ALDH5A1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr17:40,132,339...40,158,677
Ensembl chr17:40,130,883...40,158,677
|
|
G |
Aldh6a1 |
aldehyde dehydrogenase 6 family, member A1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of ALDH6A1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 6:104,077,975...104,098,636
Ensembl chr 6:104,077,979...104,098,656
|
|
G |
Aldoa |
aldolase, fructose-bisphosphate A |
decreases expression |
ISO |
Thimerosal results in decreased expression of ALDOA mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:181,402,275...181,407,476
Ensembl chr 1:181,402,275...181,406,182
|
|
G |
Aldoc |
aldolase, fructose-bisphosphate C |
decreases expression |
ISO |
Thimerosal results in decreased expression of ALDOC mRNA |
CTD |
PMID:27188386 |
|
NCBI chr10:63,217,477...63,221,066
Ensembl chr10:63,217,451...63,221,066
|
|
G |
Alg13 |
ALG13, UDP-N-acetylglucosaminyltransferase subunit |
increases expression |
ISO |
Thimerosal results in increased expression of ALG13 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr X:107,906,320...107,968,232
Ensembl chr X:107,885,093...107,942,695
|
|
G |
Alox5 |
arachidonate 5-lipoxygenase |
decreases expression |
ISO |
Thimerosal results in decreased expression of ALOX5 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 4:149,531,329...149,578,696
Ensembl chr 4:149,531,515...149,578,743
|
|
G |
Angpt1 |
angiopoietin 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of ANGPT1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 7:73,528,345...73,783,953
Ensembl chr 7:73,531,486...73,784,067
|
|
G |
Ank2 |
ankyrin 2 |
increases expression |
ISO |
Thimerosal results in increased expression of ANK2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 2:215,378,028...215,954,015
Ensembl chr 2:215,379,680...215,862,923
|
|
G |
Ankdd1a |
ankyrin repeat and death domain containing 1A |
decreases expression |
ISO |
Thimerosal results in decreased expression of ANKDD1A mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 8:66,017,571...66,043,738
Ensembl chr 8:66,017,773...66,042,651
|
|
G |
Ankef1 |
ankyrin repeat and EF-hand domain containing 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of ANKEF1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 3:123,847,832...123,883,060
Ensembl chr 3:123,847,817...123,883,059
|
|
G |
Ankrd10 |
ankyrin repeat domain 10 |
increases expression |
ISO |
Thimerosal results in increased expression of ANKRD10 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr16:77,866,489...77,889,745
Ensembl chr16:77,864,261...77,889,745
|
|
G |
Ankrd35 |
ankyrin repeat domain 35 |
decreases expression |
ISO |
Thimerosal results in decreased expression of ANKRD35 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 2:184,207,076...184,227,063
Ensembl chr 2:184,207,071...184,227,063
|
|
G |
Ankrd37 |
ankyrin repeat domain 37 |
decreases expression |
ISO |
Thimerosal results in decreased expression of ANKRD37 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr16:46,268,933...46,271,971
Ensembl chr16:46,268,443...46,271,963
|
|
G |
Ankrd44 |
ankyrin repeat domain 44 |
increases expression |
ISO |
Thimerosal results in increased expression of ANKRD44 mRNA |
CTD |
PMID:24675092 PMID:27188386 |
|
NCBI chr 9:56,126,746...56,427,661
Ensembl chr 9:56,126,747...56,427,508
|
|
G |
Ankrd9 |
ankyrin repeat domain 9 |
decreases expression |
ISO |
Thimerosal results in decreased expression of ANKRD9 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 6:130,001,914...130,008,792
Ensembl chr 6:129,998,486...130,008,923
|
|
G |
Ano4 |
anoctamin 4 |
decreases expression |
ISO |
Thimerosal results in decreased expression of ANO4 mRNA |
CTD |
PMID:24675092 |
|
NCBI chr 7:23,329,015...23,738,423
Ensembl chr 7:23,329,070...23,738,434
|
|
G |
Anp32b |
acidic nuclear phosphoprotein 32 family member B |
decreases expression |
ISO |
Thimerosal results in decreased expression of ANP32B mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 5:60,743,077...60,765,726
Ensembl chr 5:60,743,443...60,765,717
|
|
G |
Anpep |
alanyl aminopeptidase, membrane |
decreases expression |
ISO |
Thimerosal results in decreased expression of ANPEP mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:133,767,332...133,810,137
Ensembl chr 1:133,767,332...133,785,789
|
|
G |
Apc |
APC regulator of WNT signaling pathway |
increases expression |
ISO |
Thimerosal results in increased expression of APC mRNA |
CTD |
PMID:27188386 |
|
NCBI chr18:25,828,558...25,925,511
Ensembl chr18:25,864,222...25,922,696
|
|
G |
Apoh |
apolipoprotein H |
multiple interactions |
ISO |
[NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of APOH mRNA |
CTD |
PMID:27188386 |
|
NCBI chr10:93,342,435...93,356,334
Ensembl chr10:93,310,977...93,356,329
|
|
G |
Appl2 |
adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 2 |
decreases expression |
ISO |
Thimerosal results in decreased expression of APPL2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 7:20,135,248...20,184,757
Ensembl chr 7:20,135,375...20,184,754
|
|
G |
Arap3 |
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3 |
decreases expression |
ISO |
Thimerosal results in decreased expression of ARAP3 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr18:29,806,214...29,834,217
Ensembl chr18:29,807,536...29,833,555
|
|
G |
Arb2a |
ARB2 cotranscriptional regulator A |
decreases expression |
ISO |
Thimerosal results in decreased expression of ARB2A mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 2:7,553,873...8,018,183
Ensembl chr 2:7,553,891...8,018,162
|
|
G |
Arc |
activity-regulated cytoskeleton-associated protein |
increases expression |
ISO |
Thimerosal results in increased expression of ARC mRNA |
CTD |
PMID:16870260 |
|
NCBI chr 7:106,555,968...106,559,697
Ensembl chr 7:106,555,785...106,559,378
|
|
G |
Arfgef3 |
ARFGEF family member 3 |
decreases expression |
ISO |
Thimerosal results in decreased expression of ARFGEF3 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:13,245,578...13,404,319
Ensembl chr 1:13,244,830...13,404,084
|
|
G |
Arglu1 |
arginine and glutamate rich 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of ARGLU1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr16:80,753,300...80,777,350
Ensembl chr16:80,753,315...80,777,349
|
|
G |
Arhgap18 |
Rho GTPase activating protein 18 |
decreases expression |
ISO |
Thimerosal results in decreased expression of ARHGAP18 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:18,403,531...18,637,306
Ensembl chr 1:18,403,537...18,637,256
|
|
G |
Arhgap5 |
Rho GTPase activating protein 5 |
increases expression |
ISO |
Thimerosal results in increased expression of ARHGAP5 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 6:69,975,904...70,039,299
Ensembl chr 6:69,976,214...70,037,660
|
|
G |
Arhgef10 |
Rho guanine nucleotide exchange factor 10 |
decreases expression |
ISO |
Thimerosal results in decreased expression of ARHGEF10 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr16:74,647,147...74,738,784
Ensembl chr16:74,647,153...74,738,173
|
|
G |
Arhgef12 |
Rho guanine nucleotide exchange factor 12 |
increases expression |
ISO |
Thimerosal results in increased expression of ARHGEF12 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 8:43,350,070...43,475,404
Ensembl chr 8:43,353,799...43,476,366
|
|
G |
Arhgef4 |
Rho guanine nucleotide exchange factor 4 |
decreases expression |
ISO |
Thimerosal results in decreased expression of ARHGEF4 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 9:36,861,800...37,005,079
Ensembl chr 9:36,861,835...37,005,075
|
|
G |
Armc7 |
armadillo repeat containing 7 |
decreases expression |
ISO |
Thimerosal results in decreased expression of ARMC7 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr10:100,723,080...100,739,636
Ensembl chr10:100,723,105...100,739,636
|
|
G |
Armcx5 |
armadillo repeat containing, X-linked 5 |
increases expression |
ISO |
Thimerosal results in increased expression of ARMCX5 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr X:98,709,921...98,714,347
Ensembl chr X:98,709,841...98,714,674
|
|
G |
Arnt |
aryl hydrocarbon receptor nuclear translocator |
decreases expression |
ISO |
Thimerosal results in decreased expression of ARNT mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 2:182,997,731...183,056,584
Ensembl chr 2:182,997,736...183,056,580
|
|
G |
Arpc1b |
actin related protein 2/3 complex, subunit 1B |
decreases expression |
ISO |
Thimerosal results in decreased expression of ARPC1B mRNA |
CTD |
PMID:27188386 |
|
NCBI chr12:9,482,176...9,495,772
Ensembl chr12:9,480,831...9,495,747
|
|
G |
Arrdc3 |
arrestin domain containing 3 |
increases expression |
ISO |
Thimerosal results in increased expression of ARRDC3 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 2:11,137,464...11,149,978
Ensembl chr 2:11,137,460...11,149,978
|
|
G |
Arsk |
arylsulfatase family, member K |
decreases expression |
ISO |
Thimerosal results in decreased expression of ARSK mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 2:5,574,319...5,631,451
Ensembl chr 2:5,574,322...5,631,467
|
|
G |
Asf1a |
anti-silencing function 1A histone chaperone |
increases expression |
ISO |
Thimerosal results in increased expression of ASF1A mRNA |
CTD |
PMID:27188386 |
|
NCBI chr20:32,893,962...32,908,808
Ensembl chr20:32,893,573...32,908,808
|
|
G |
Asmtl |
acetylserotonin O-methyltransferase-like |
decreases expression |
ISO |
Thimerosal results in decreased expression of ASMTL mRNA |
CTD |
PMID:27188386 |
|
NCBI chr12:16,315,335...16,318,083
Ensembl chr12:16,315,414...16,318,080
|
|
G |
Aspm |
assembly factor for spindle microtubules |
decreases expression |
ISO |
Thimerosal results in decreased expression of ASPM mRNA |
CTD |
PMID:27188386 |
|
NCBI chr13:51,074,849...51,123,755
Ensembl chr13:51,074,849...51,123,755
|
|
G |
Atad2b |
ATPase family, AAA domain containing 2B |
increases expression |
ISO |
Thimerosal results in increased expression of ATAD2B mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 6:27,914,546...28,070,103
Ensembl chr 6:27,912,862...28,067,047
|
|
G |
Atf3 |
activating transcription factor 3 |
increases expression |
ISO |
Thimerosal results in increased expression of ATF3 mRNA |
CTD |
PMID:16870260 |
|
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
|
|
G |
Atf7ip |
activating transcription factor 7 interacting protein |
increases expression |
ISO |
Thimerosal results in increased expression of ATF7IP mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 4:169,385,872...169,471,652
Ensembl chr 4:169,385,872...169,471,650
|
|
G |
Atg10 |
autophagy related 10 |
increases expression |
ISO |
Thimerosal results in increased expression of ATG10 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 2:22,109,304...22,398,313
Ensembl chr 2:22,108,426...22,398,233
|
|
G |
Atg13 |
autophagy related 13 |
decreases expression |
ISO |
Thimerosal results in decreased expression of ATG13 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 3:77,647,069...77,681,028
Ensembl chr 3:77,645,790...77,681,043
|
|
G |
Atg2b |
autophagy related 2B |
decreases expression |
ISO |
Thimerosal results in decreased expression of ATG2B mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 6:124,522,283...124,592,412
Ensembl chr 6:124,525,523...124,592,015
|
|
G |
Atm |
ATM serine/threonine kinase |
increases expression |
ISO |
Thimerosal results in increased expression of ATM mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
|
|
G |
Atp11b |
ATPase phospholipid transporting 11B (putative) |
decreases expression |
ISO |
Thimerosal results in decreased expression of ATP11B mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 2:118,585,348...118,691,076
Ensembl chr 2:118,585,342...118,690,232
|
|
G |
Atp13a3 |
ATPase 13A3 |
decreases expression |
ISO |
Thimerosal results in decreased expression of ATP13A3 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr11:70,364,998...70,442,005
Ensembl chr11:70,365,322...70,441,235
|
|
G |
Atp1b2 |
ATPase Na+/K+ transporting subunit beta 2 |
decreases expression |
ISO |
Thimerosal results in decreased expression of ATP1B2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr10:54,318,698...54,324,933
Ensembl chr10:54,318,701...54,324,933
|
|
G |
Atp5f1d |
ATP synthase F1 subunit delta |
decreases expression |
ISO |
Thimerosal results in decreased expression of ATP5F1D mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 7:9,560,604...9,565,919
Ensembl chr 7:9,560,608...9,565,929
|
|
G |
Atp5f1e |
ATP synthase F1 subunit epsilon |
increases expression |
ISO |
Thimerosal results in increased expression of ATP5F1E mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 3:163,259,072...163,261,974
Ensembl chr 3:163,260,476...163,261,450
|
|
G |
Atp5if1 |
ATP synthase inhibitory factor subunit 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of ATP5IF1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 5:144,738,950...144,742,668
Ensembl chr 5:144,738,950...144,742,668
|
|
G |
Atp6v1d |
ATPase H+ transporting V1 subunit D |
increases expression |
ISO |
Thimerosal results in increased expression of ATP6V1D mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 6:97,656,725...97,672,295
Ensembl chr 6:97,656,576...97,672,303
|
|
G |
Atp8b3 |
ATPase phospholipid transporting 8B3 |
decreases expression |
ISO |
Thimerosal results in decreased expression of ATP8B3 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 7:9,175,544...9,195,449
Ensembl chr 7:9,175,391...9,195,442
|
|
G |
Atrx |
ATRX, chromatin remodeler |
decreases expression |
ISO |
Thimerosal results in decreased expression of ATRX mRNA |
CTD |
PMID:27188386 |
|
NCBI chr X:70,850,981...70,997,330
Ensembl chr X:70,850,981...70,997,330
|
|
G |
Atxn1 |
ataxin 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of ATXN1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr17:18,737,491...19,142,360
Ensembl chr17:18,737,533...19,142,360
|
|
G |
Atxn7l3b |
ataxin 7-like 3B |
decreases expression |
ISO |
Thimerosal results in decreased expression of ATXN7L3B mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 7:48,322,451...48,325,975
Ensembl chr 7:48,321,755...48,328,878
|
|
G |
Azi2 |
5-azacytidine induced 2 |
increases expression |
ISO |
Thimerosal results in increased expression of AZI2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 8:117,773,248...117,797,844
Ensembl chr 8:117,773,279...117,797,847
|
|
G |
B3galnt2 |
beta-1,3-N-acetylgalactosaminyltransferase 2 |
increases expression |
ISO |
Thimerosal results in increased expression of B3GALNT2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr17:51,334,921...51,377,469
Ensembl chr17:51,334,921...51,377,469
|
|
G |
Bace1 |
beta-secretase 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of BACE1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 8:46,142,060...46,166,268
Ensembl chr 8:46,142,116...46,165,876
|
|
G |
Bace2 |
beta-secretase 2 |
decreases expression |
ISO |
Thimerosal results in decreased expression of BACE2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr11:36,707,447...36,789,550
Ensembl chr11:36,707,458...36,789,546
|
|
G |
Bag3 |
BAG cochaperone 3 |
increases expression |
ISO |
Thimerosal results in increased expression of BAG3 mRNA |
CTD |
PMID:16870260 |
|
NCBI chr 1:183,103,038...183,126,862
Ensembl chr 1:183,102,871...183,126,858
|
|
G |
Bag4 |
BAG cochaperone 4 |
decreases expression |
ISO |
Thimerosal results in decreased expression of BAG4 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr16:66,288,678...66,305,893
Ensembl chr16:66,288,678...66,308,663
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression |
ISO |
Thimerosal results in increased expression of BAX |
CTD |
PMID:24942245 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bbip1 |
BBSome interacting protein 1 |
increases expression |
ISO |
Thimerosal results in increased expression of BBIP1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:252,943,589...252,959,512
Ensembl chr 1:252,945,557...252,959,352
|
|
G |
Bbln |
bublin coiled coil protein |
decreases expression |
ISO |
Thimerosal results in decreased expression of BBLN mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 3:15,674,577...15,677,322
Ensembl chr 3:15,674,580...15,677,374
|
|
G |
Bcas3 |
BCAS3, microtubule associated cell migration factor |
decreases expression |
ISO |
Thimerosal results in decreased expression of BCAS3 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr10:70,213,710...70,673,080
Ensembl chr10:70,214,098...70,673,080
|
|
G |
Bcat2 |
branched chain amino acid transaminase 2 |
decreases expression |
ISO |
Thimerosal results in decreased expression of BCAT2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:96,040,407...96,060,008
Ensembl chr 1:96,042,625...96,060,007
|
|
G |
Bcl6b |
BCL6B, transcription repressor |
decreases expression |
ISO |
Thimerosal results in decreased expression of BCL6B mRNA |
CTD |
PMID:27188386 |
|
NCBI chr10:54,940,908...54,947,022
Ensembl chr10:54,940,909...54,945,974
|
|
G |
Bclaf1 |
BCL2-associated transcription factor 1 |
increases expression |
ISO |
Thimerosal results in increased expression of BCLAF1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:15,088,436...15,117,666
Ensembl chr 1:15,070,894...15,148,832
|
|
G |
Bcor |
BCL6 co-repressor |
decreases expression |
ISO |
Thimerosal results in decreased expression of BCOR mRNA |
CTD |
PMID:27188386 |
|
NCBI chr X:10,609,756...10,729,613
Ensembl chr X:10,687,732...10,729,613
|
|
G |
Bdp1 |
BDP1 general transcription factor IIIB subunit |
decreases expression |
ISO |
Thimerosal results in decreased expression of BDP1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 2:31,378,407...31,470,140
Ensembl chr 2:31,378,924...31,470,119
|
|
G |
Bhlhe40 |
basic helix-loop-helix family, member e40 |
decreases expression |
ISO |
Thimerosal results in decreased expression of BHLHE40 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 4:141,618,453...141,624,154
Ensembl chr 4:141,618,476...141,624,774
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
multiple interactions decreases expression |
ISO |
Glutathione inhibits the reaction [Thimerosal results in decreased expression of BIRC3 protein] |
CTD |
PMID:12140745 |
|
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
multiple interactions decreases expression |
ISO |
BIRC5 mutant form promotes the reaction [Thimerosal results in increased cleavage of CASP3 protein]; BIRC5 mutant form promotes the reaction [Thimerosal results in increased cleavage of CASP9 protein]; BIRC5 protein inhibits the reaction [Thimerosal results in increased cleavage of CASP3 protein]; BIRC5 protein inhibits the reaction [Thimerosal results in increased cleavage of CASP9 protein]; IGF1 protein inhibits the reaction [Thimerosal results in decreased expression of BIRC5 protein]; Thimerosal promotes the reaction [BIRC5 mutant form results in increased cleavage of CASP3 protein]; Thimerosal promotes the reaction [BIRC5 mutant form results in increased cleavage of CASP9 protein] |
CTD |
PMID:23145070 |
|
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Bloc1s3 |
biogenesis of lysosomal organelles complex-1, subunit 3 |
decreases expression |
ISO |
Thimerosal results in decreased expression of BLOC1S3 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:79,155,873...79,158,247
Ensembl chr 1:79,155,693...79,158,505
|
|
G |
Bltp3a |
bridge-like lipid transfer protein family member 3A |
decreases expression |
ISO |
Thimerosal results in decreased expression of BLTP3A mRNA |
CTD |
PMID:24675092 |
|
NCBI chr20:5,910,261...5,954,641
Ensembl chr20:5,910,260...5,952,404
|
|
G |
Bmp2k |
BMP-2 inducible kinase |
increases expression |
ISO |
Thimerosal results in increased expression of BMP2K mRNA |
CTD |
PMID:27188386 |
|
NCBI chr14:12,481,194...12,579,411
Ensembl chr14:12,484,729...12,579,134
|
|
G |
Bnip3 |
BCL2 interacting protein 3 |
decreases expression |
ISO |
Thimerosal results in decreased expression of BNIP3 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:193,708,164...193,725,348
Ensembl chr 1:193,708,167...193,725,359
|
|
G |
Bod1l1 |
biorientation of chromosomes in cell division 1-like 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of BOD1L1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr14:69,108,483...69,163,255
Ensembl chr14:69,108,491...69,162,490
|
|
G |
Bok |
BCL2 family apoptosis regulator BOK |
decreases expression |
ISO |
Thimerosal results in decreased expression of BOK mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 9:94,223,493...94,234,476
Ensembl chr 9:94,223,389...94,234,476
|
|
G |
Bola2 |
bolA family member 2 |
increases expression |
ISO |
Thimerosal results in increased expression of BOLA2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:181,291,967...181,292,833
Ensembl chr 1:181,291,398...181,292,676
|
|
G |
Brca2 |
BRCA2, DNA repair associated |
increases expression |
ISO |
Thimerosal results in increased expression of BRCA2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr12:59,492...103,789
Ensembl chr12:59,819...100,567
|
|
G |
Brwd1 |
bromodomain and WD repeat domain containing 1 |
increases expression |
ISO |
Thimerosal results in increased expression of BRWD1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr11:35,286,364...35,378,768
Ensembl chr11:35,288,313...35,378,768
|
|
G |
Brwd3 |
bromodomain and WD repeat domain containing 3 |
decreases expression |
ISO |
Thimerosal results in decreased expression of BRWD3 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr X:73,768,343...73,861,643
Ensembl chr X:73,774,340...73,861,622
|
|
G |
Btg3 |
BTG anti-proliferation factor 3 |
increases expression |
ISO |
Thimerosal results in increased expression of BTG3 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr11:17,030,156...17,046,069
Ensembl chr11:17,030,160...17,046,170
|
|
G |
C11h3orf38 |
similar to human chromosome 3 open reading frame 38 |
increases expression |
ISO |
Thimerosal results in increased expression of C3ORF38 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr11:2,483,983...2,488,631
Ensembl chr11:2,481,189...2,488,660
|
|
G |
C13h1orf115 |
similar to human chromosome 1 open reading frame 115 |
decreases expression |
ISO |
Thimerosal results in decreased expression of C1ORF115 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr13:96,422,308...96,432,044
Ensembl chr13:96,422,302...96,432,068
|
|
G |
C13h1orf53 |
similar to human chromosome 1 open reading frame 53 |
increases expression |
ISO |
Thimerosal results in increased expression of C1ORF53 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr13:50,413,785...50,418,974
Ensembl chr13:50,413,785...50,419,120
|
|
G |
C13h2orf76 |
similar to chromosome 2 open reading frame 76 |
increases expression |
ISO |
Thimerosal results in increased expression of C2ORF76 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr13:31,249,733...31,335,367
Ensembl chr13:31,249,959...31,314,943
|
|
G |
C15h8orf58 |
similar to human chromosome 8 open reading frame 58 |
decreases expression |
ISO |
Thimerosal results in decreased expression of C8ORF58 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr15:45,228,615...45,235,274
Ensembl chr15:45,228,615...45,233,254
|
|
G |
C16h8orf48 |
similar to human chromosome 8 open reading frame 48 |
increases expression |
ISO |
Thimerosal results in increased expression of C8ORF48 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr16:55,244,744...55,246,642
Ensembl chr16:55,236,322...55,246,650
|
|
G |
C17h5orf24 |
similar to human chromosome 5 open reading frame 24 |
decreases expression |
ISO |
Thimerosal results in decreased expression of C5ORF24 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr17:8,923,041...8,932,958
Ensembl chr17:8,922,675...8,933,356
|
|
G |
C1qtnf3 |
C1q and TNF related 3 |
decreases expression |
ISO |
Thimerosal results in decreased expression of C1QTNF3 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 2:59,917,099...59,939,519
Ensembl chr 2:59,917,188...59,939,433
|
|
G |
C1qtnf4 |
C1q and TNF related 4 |
decreases expression |
ISO |
Thimerosal results in decreased expression of C1QTNF4 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 3:76,854,368...76,872,991
Ensembl chr 3:76,857,735...76,874,139
|
|
G |
C1rl |
complement C1r subcomponent like |
decreases expression |
ISO |
Thimerosal results in decreased expression of C1RL mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 4:157,394,183...157,410,771
Ensembl chr 4:157,394,200...157,410,134
|
|
G |
C20h6orf136 |
similar to human chromosome 6 open reading frame 136 |
decreases expression |
ISO |
Thimerosal results in decreased expression of C6ORF136 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr20:2,857,840...2,861,952
|
|
G |
C2cd2 |
C2 calcium-dependent domain containing 2 |
decreases expression |
ISO |
Thimerosal results in decreased expression of C2CD2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr11:37,225,321...37,289,741
Ensembl chr11:37,227,415...37,289,739
|
|
G |
C5h1orf174 |
similar to human chromosome 1 open reading frame 174 |
increases expression |
ISO |
Thimerosal results in increased expression of C1ORF174 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 5:164,515,578...164,520,022
Ensembl chr 5:164,515,559...164,520,021
|
|
G |
C7h8orf82 |
similar to human chromosome 8 open reading frame 82 |
decreases expression |
ISO |
Thimerosal results in decreased expression of C8ORF82 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 7:108,443,772...108,446,116
Ensembl chr 7:108,443,782...108,446,121
|
|
G |
Cadm2 |
cell adhesion molecule 2 |
increases expression |
ISO |
Thimerosal results in increased expression of CADM2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr11:4,548,367...5,525,420
Ensembl chr11:4,555,159...5,525,400
|
|
G |
Cadm3 |
cell adhesion molecule 3 |
decreases expression |
ISO |
Thimerosal results in decreased expression of CADM3 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr13:85,784,785...85,817,412
Ensembl chr13:85,786,483...85,817,749
|
|
G |
Calm3 |
calmodulin 3 |
decreases expression |
ISO |
Thimerosal results in decreased expression of CALM3 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:77,590,668...77,597,776
Ensembl chr 1:77,589,230...77,592,207
|
|
G |
Calml4 |
calmodulin-like 4 |
multiple interactions |
ISO |
[NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CALML4 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 8:63,323,426...63,335,234
Ensembl chr 8:63,323,351...63,335,234
|
|
G |
Capn5 |
calpain 5 |
multiple interactions |
ISO |
[NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CAPN5 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:152,416,252...152,472,923
Ensembl chr 1:152,416,252...152,472,923
|
|
G |
Capn9 |
calpain 9 |
increases expression |
ISO |
Thimerosal results in increased expression of CAPN9 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr19:52,549,448...52,586,413
Ensembl chr19:52,549,448...52,586,413
|
|
G |
Car10 |
carbonic anhydrase 10 |
increases expression |
ISO |
Thimerosal results in increased expression of CA10 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr10:78,055,875...78,556,490
Ensembl chr10:78,054,114...78,555,834
|
|
G |
Car14 |
carbonic anhydrase 14 |
decreases expression |
ISO |
Thimerosal results in decreased expression of CA14 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 2:183,442,263...183,449,231
Ensembl chr 2:183,441,667...183,449,693
|
|
G |
Card10 |
caspase recruitment domain family, member 10 |
decreases expression |
ISO |
Thimerosal results in decreased expression of CARD10 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 7:110,330,460...110,371,551
Ensembl chr 7:110,330,408...110,359,224
|
|
G |
Carm1 |
coactivator-associated arginine methyltransferase 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of CARM1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 8:20,097,262...20,141,950
Ensembl chr 8:20,097,254...20,147,689
|
|
G |
Casp3 |
caspase 3 |
increases cleavage multiple interactions increases activity |
ISO EXP |
Thimerosal results in increased cleavage of CASP3 protein [[Thimerosal results in increased abundance of Reactive Oxygen Species] which results in increased activity of CASP3 protein] which results in increased cleavage of PTK2 protein; [SOD1 protein results in increased susceptibility to Thimerosal] which results in increased cleavage of CASP3 protein; [Thimerosal results in increased abundance of Reactive Oxygen Species] which results in increased activity of CASP3 protein; Acetylcysteine inhibits the reaction [[[Thimerosal results in increased abundance of Reactive Oxygen Species] which results in increased activity of CASP3 protein] which results in increased cleavage of PTK2 protein]; benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[[Thimerosal results in increased abundance of Reactive Oxygen Species] which results in increased activity of CASP3 protein] which results in increased cleavage of PTK2 protein]; Glutathione inhibits the reaction [Thimerosal results in increased activity of CASP3 protein]; Resveratrol inhibits the reaction [[SOD1 protein results in increased susceptibility to Thimerosal] which results in increased cleavage of CASP3 protein]; SB 203580 inhibits the reaction [Thimerosal results in increased activity of CASP3 protein] benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [Thimerosal results in increased cleavage of CASP3 protein]; benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [Thimerosal results in increased cleavage of CASP3 protein]; BIRC5 mutant form promotes the reaction [Thimerosal results in increased cleavage of CASP3 protein]; BIRC5 protein inhibits the reaction [Thimerosal results in increased cleavage of CASP3 protein]; IGF1 protein inhibits the reaction [Thimerosal results in increased cleavage of CASP3 protein]; Thimerosal promotes the reaction [BIRC5 mutant form results in increased cleavage of CASP3 protein]; Thimerosal promotes the reaction [Wortmannin results in increased cleavage of CASP3 protein]; Wortmannin promotes the reaction [Thimerosal results in increased cleavage of CASP3 protein] MC1568 inhibits the reaction [Thimerosal results in increased cleavage of and results in increased activity of CASP3 protein]; Thimerosal results in increased cleavage of and results in increased activity of CASP3 protein |
CTD |
PMID:12140745 PMID:15869795 PMID:16649253 PMID:17698513 PMID:17888894 PMID:23145070 PMID:27660204 PMID:30503815 More...
|
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp9 |
caspase 9 |
increases cleavage multiple interactions increases activity |
ISO |
Thimerosal results in increased cleavage of CASP9 protein Glutathione inhibits the reaction [Thimerosal results in increased activity of CASP9 protein] benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [Thimerosal results in increased cleavage of CASP9 protein]; BIRC5 mutant form promotes the reaction [Thimerosal results in increased cleavage of CASP9 protein]; BIRC5 protein inhibits the reaction [Thimerosal results in increased cleavage of CASP9 protein]; IGF1 protein inhibits the reaction [Thimerosal results in increased cleavage of CASP9 protein]; Thimerosal promotes the reaction [BIRC5 mutant form results in increased cleavage of CASP9 protein]; Thimerosal promotes the reaction [wortmannin results in increased cleavage of CASP9 protein]; wortmannin promotes the reaction [Thimerosal results in increased cleavage of CASP9 protein] |
CTD |
PMID:12140745 PMID:15869795 PMID:23145070 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
multiple interactions |
ISO |
[Thimerosal co-treated with Aluminum Hydroxide] results in increased activity of CAT protein |
CTD |
PMID:36411272 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cbl |
Cbl proto-oncogene |
decreases expression |
ISO |
Thimerosal results in decreased expression of CBL mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 8:44,487,824...44,571,620
Ensembl chr 8:44,489,410...44,571,176
|
|
G |
Cbx3 |
chromobox 3 |
increases expression |
ISO |
Thimerosal results in increased expression of CBX3 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 4:80,545,450...80,559,284
Ensembl chr 4:80,546,010...80,559,283
|
|
G |
Cbx5 |
chromobox 5 |
decreases expression |
ISO |
Thimerosal results in decreased expression of CBX5 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 7:134,333,165...134,376,102
Ensembl chr 7:134,331,335...134,375,022
|
|
G |
Cbx7 |
chromobox 7 |
decreases expression |
ISO |
Thimerosal results in decreased expression of CBX7 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 7:111,460,656...111,479,231
Ensembl chr 7:111,460,656...111,477,973
|
|
G |
Cc2d2b |
coiled-coil and C2 domain containing 2B |
decreases expression |
ISO |
Thimerosal results in decreased expression of CC2D2B mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:239,561,506...239,655,771
Ensembl chr 1:239,561,987...239,682,416
|
|
G |
Ccdc113 |
coiled-coil domain containing 113 |
decreases expression |
ISO |
Thimerosal results in decreased expression of CFAP263 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr19:9,497,000...9,516,917
Ensembl chr19:9,496,886...9,516,923
|
|
G |
Ccdc126 |
coiled-coil domain containing 126 |
increases expression |
ISO |
Thimerosal results in increased expression of CCDC126 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 4:78,297,625...78,318,655
Ensembl chr 4:78,297,551...78,318,655
|
|
G |
Ccdc183 |
coiled-coil domain containing 183 |
decreases expression |
ISO |
Thimerosal results in decreased expression of CCDC183 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 3:8,428,784...8,438,948
Ensembl chr 3:8,428,787...8,437,194
|
|
G |
Ccdc186 |
coiled-coil domain containing 186 |
decreases expression |
ISO |
Thimerosal results in decreased expression of CCDC186 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:255,831,663...255,871,954
Ensembl chr 1:255,839,595...255,871,935
|
|
G |
Ccdc66 |
coiled-coil domain containing 66 |
increases expression |
ISO |
Thimerosal results in increased expression of CCDC66 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr16:2,662,125...2,694,031
Ensembl chr16:2,662,131...2,694,023
|
|
G |
Ccdc71l |
coiled-coil domain containing 71-like |
decreases expression |
ISO |
Thimerosal results in decreased expression of CCDC71L mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 6:48,960,020...48,964,112
Ensembl chr 6:48,960,191...48,960,841 Ensembl chr 6:48,960,191...48,960,841
|
|
G |
Ccdc82 |
coiled-coil domain containing 82 |
increases expression |
ISO |
Thimerosal results in increased expression of CCDC82 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 8:10,227,727...10,265,963
Ensembl chr 8:10,228,430...10,265,963
|
|
G |
Ccdc85b |
coiled-coil domain containing 85B |
decreases expression |
ISO |
Thimerosal results in decreased expression of CCDC85B mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:202,763,645...202,764,660
Ensembl chr 1:202,763,631...202,764,703
|
|
G |
Ccm2l |
CCM2 like scaffold protein |
decreases expression |
ISO |
Thimerosal results in decreased expression of CCM2L mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 3:141,533,470...141,549,136
Ensembl chr 3:141,533,511...141,549,140
|
|
G |
Ccn1 |
cellular communication network factor 1 |
increases expression |
ISO |
Thimerosal results in increased expression of CCN1 mRNA |
CTD |
PMID:16870260 |
|
NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484
|
|
G |
Ccnb1 |
cyclin B1 |
multiple interactions |
ISO |
Thimerosal results in increased expression of and results in increased activity of CCNB1 protein |
CTD |
PMID:16649253 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Ccnd1 |
cyclin D1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of CCND1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccnd2 |
cyclin D2 |
decreases expression |
ISO |
Thimerosal results in decreased expression of CCND2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 4:159,966,883...159,989,261
Ensembl chr 4:159,962,363...159,989,495
|
|
G |
Ccnt1 |
cyclin T1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of CCNT1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 7:129,687,146...129,718,080
Ensembl chr 7:129,691,209...129,717,871
|
|
G |
Ccnt2 |
cyclin T2 |
increases expression |
ISO |
Thimerosal results in increased expression of CCNT2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr13:39,251,573...39,293,172
Ensembl chr13:39,251,573...39,292,019
|
|
G |
Ccser1 |
coiled-coil serine-rich protein 1 |
increases expression |
ISO |
Thimerosal results in increased expression of CCSER1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 4:90,153,873...91,391,441
Ensembl chr 4:90,292,780...91,388,786
|
|
G |
Cct6b |
chaperonin containing TCP1 subunit 6B |
increases expression |
ISO |
Thimerosal results in increased expression of CCT6B mRNA |
CTD |
PMID:27188386 |
|
NCBI chr10:67,652,461...67,701,385
Ensembl chr10:67,652,546...67,701,284
|
|
G |
Cd28 |
Cd28 molecule |
affects response to substance |
ISO |
CD28 affects the susceptibility to Thimerosal |
CTD |
PMID:15808517 |
|
NCBI chr 9:62,166,324...62,194,674
Ensembl chr 9:62,166,192...62,194,685
|
|
G |
Cd40 |
CD40 molecule |
decreases expression |
ISO |
Thimerosal results in decreased expression of CD40 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
|
|
G |
Cd6 |
Cd6 molecule |
decreases expression |
ISO |
Thimerosal results in decreased expression of CD6 mRNA |
CTD |
PMID:24675092 |
|
NCBI chr 1:207,442,873...207,481,703
Ensembl chr 1:207,442,877...207,481,634
|
|
G |
Cd79b |
CD79b molecule |
increases expression |
ISO |
Thimerosal results in increased expression of CD79B mRNA |
CTD |
PMID:24675092 |
|
NCBI chr10:91,239,354...91,242,500
Ensembl chr10:91,239,356...91,242,625
|
|
G |
Cd81 |
Cd81 molecule |
decreases expression |
ISO |
Thimerosal results in decreased expression of CD81 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:198,235,861...198,251,660
Ensembl chr 1:198,241,484...198,251,660
|
|
G |
Cd86 |
CD86 molecule |
multiple interactions increases expression |
ISO |
Acetylcysteine inhibits the reaction [Thimerosal results in increased expression of CD86 protein]; Cysteine inhibits the reaction [Thimerosal results in increased expression of CD86 protein]; Glutathione inhibits the reaction [Thimerosal results in increased expression of CD86 protein]; Vitamin E inhibits the reaction [Thimerosal results in increased expression of CD86 protein] |
CTD |
PMID:15737199 PMID:20417223 PMID:20457211 |
|
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
|
|
G |
Cd99 |
CD99 molecule (Xg blood group) |
decreases expression |
ISO |
Thimerosal results in decreased expression of CD99 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr20:54,418,239...54,422,882
|
|
G |
Cdc20b |
cell division cycle 20B |
increases expression |
ISO |
Thimerosal results in increased expression of CDC20B mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 2:44,688,349...44,738,056
|
|
G |
Cdc27 |
cell division cycle 27 |
decreases expression |
ISO |
Thimerosal results in decreased expression of CDC27 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr10:89,400,720...89,449,816
Ensembl chr10:89,400,940...89,449,736
|
|
G |
Cdc37l1 |
cell division cycle 37-like 1 |
increases expression |
ISO |
Thimerosal results in increased expression of CDC37L1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:226,705,019...226,733,994
Ensembl chr 1:226,705,003...226,761,175
|
|
G |
Cdc42se2 |
CDC42 small effector 2 |
increases expression |
ISO |
Thimerosal results in increased expression of CDC42SE2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr10:38,836,549...38,905,056
Ensembl chr10:38,836,555...38,905,059 Ensembl chr 1:38,836,555...38,905,059
|
|
G |
Cdca2 |
cell division cycle associated 2 |
decreases expression |
ISO |
Thimerosal results in decreased expression of CDCA2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr15:41,895,946...41,942,226
Ensembl chr15:41,895,901...41,941,611
|
|
G |
Cdh8 |
cadherin 8 |
increases expression |
ISO |
Thimerosal results in increased expression of CDH8 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr19:5,494,038...5,901,810
Ensembl chr19:5,494,174...5,895,669
|
|
G |
Cdhr1 |
cadherin-related family member 1 |
increases expression |
ISO |
Thimerosal results in increased expression of CDHR1 mRNA |
CTD |
PMID:24675092 |
|
NCBI chr16:12,843,436...12,863,321
Ensembl chr16:12,843,437...12,863,396
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
increases expression |
ISO |
Thimerosal results in increased expression of CDK1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
|
|
G |
Cdk14 |
cyclin-dependent kinase 14 |
affects expression |
ISO |
Thimerosal affects the expression of CDK14 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 4:28,666,416...29,258,865
Ensembl chr 4:28,666,843...29,258,861
|
|
G |
Cdk16 |
cyclin-dependent kinase 16 |
decreases expression |
ISO |
Thimerosal results in decreased expression of CDK16 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr X:1,492,814...1,504,309
Ensembl chr X:1,492,814...1,504,148
|
|
G |
Cdk4 |
cyclin-dependent kinase 4 |
decreases expression |
ISO |
Thimerosal results in decreased expression of CDK4 protein |
CTD |
PMID:16649253 |
|
NCBI chr 7:62,886,124...62,889,562
Ensembl chr 7:62,883,105...62,942,403
|
|
G |
Cdk6 |
cyclin-dependent kinase 6 |
decreases expression |
ISO |
Thimerosal results in decreased expression of CDK6 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 4:30,637,650...30,829,688
Ensembl chr 4:30,646,460...30,829,634
|
|
G |
Cdkn1c |
cyclin-dependent kinase inhibitor 1C |
decreases expression |
ISO |
Thimerosal results in decreased expression of CDKN1C mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:198,655,394...198,658,097
Ensembl chr 1:198,655,407...198,658,048
|
|
G |
Cdt1 |
chromatin licensing and DNA replication factor 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of CDT1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr19:50,620,713...50,625,659
Ensembl chr19:50,620,713...50,625,659
|
|
G |
Cenpn |
centromere protein N |
increases expression |
ISO |
Thimerosal results in increased expression of CENPN mRNA |
CTD |
PMID:27188386 |
|
NCBI chr19:44,971,265...44,994,019
Ensembl chr19:44,968,308...44,994,012
|
|
G |
Cenpq |
centromere protein Q |
increases expression |
ISO |
Thimerosal results in increased expression of CENPQ mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 9:19,957,122...19,972,807
Ensembl chr 9:19,957,048...19,972,789
|
|
G |
Cenpu |
centromere protein U |
increases expression |
ISO |
Thimerosal results in increased expression of CENPU mRNA |
CTD |
PMID:27188386 |
|
NCBI chr16:45,715,821...45,739,038
Ensembl chr16:45,714,294...45,738,823
|
|
G |
Cep126 |
centrosomal protein 126 |
decreases expression |
ISO |
Thimerosal results in decreased expression of CEP126 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 8:5,200,576...5,267,740
Ensembl chr 8:5,218,509...5,267,467
|
|
G |
Cep350 |
centrosomal protein 350 |
decreases expression |
ISO |
Thimerosal results in decreased expression of CEP350 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr13:68,023,327...68,164,478
Ensembl chr13:68,026,891...68,165,214
|
|
G |
Cep89 |
centrosomal protein 89 |
decreases expression |
ISO |
Thimerosal results in decreased expression of CEP89 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:88,058,211...88,100,114
Ensembl chr 1:88,058,227...88,100,112
|
|
G |
Cfap300 |
cilia and flagella associated protein 300 |
increases expression |
ISO |
Thimerosal results in increased expression of CFAP300 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 8:5,180,180...5,198,840
Ensembl chr 8:5,180,675...5,198,807
|
|
G |
Cfap44 |
cilia and flagella associated protein 44 |
increases expression |
ISO |
Thimerosal results in increased expression of CFAP44 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr11:56,199,772...56,283,964
Ensembl chr11:56,201,049...56,283,986
|
|
G |
Cfap96 |
cilia and flagella associated protein 96 |
decreases expression |
ISO |
Thimerosal results in decreased expression of CFAP96 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr16:46,291,075...46,315,616
Ensembl chr16:46,291,311...46,315,625
|
|
G |
Cfp |
complement factor properdin |
decreases expression |
ISO |
Thimerosal results in decreased expression of CFP mRNA |
CTD |
PMID:24675092 |
|
NCBI chr X:1,162,014...1,167,576
Ensembl chr X:1,161,979...1,167,573
|
|
G |
Cga |
glycoprotein hormones, alpha polypeptide |
increases expression |
ISO |
Thimerosal results in increased expression of CGA mRNA |
CTD |
PMID:24675092 |
|
NCBI chr 5:49,486,915...49,499,192
Ensembl chr 5:49,487,068...49,499,191
|
|
G |
Chchd10 |
coiled-coil-helix-coiled-coil-helix domain containing 10 |
decreases expression |
ISO |
Thimerosal results in decreased expression of CHCHD10 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr20:12,725,839...12,727,638
Ensembl chr20:12,725,842...12,732,763
|
|
G |
Chd4 |
chromodomain helicase DNA binding protein 4 |
decreases expression |
ISO |
Thimerosal results in decreased expression of CHD4 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 4:157,898,503...157,931,632
Ensembl chr 4:157,899,391...157,931,541
|
|
G |
Chd9 |
chromodomain helicase DNA binding protein 9 |
increases expression |
ISO |
Thimerosal results in increased expression of CHD9 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr19:15,941,535...16,146,220
Ensembl chr19:15,942,687...16,164,556
|
|
G |
Chmp5 |
charged multivesicular body protein 5 |
increases expression |
ISO |
Thimerosal results in increased expression of CHMP5 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 5:56,081,385...56,098,529
Ensembl chr 5:56,081,343...56,098,529
|
|
G |
Chn2 |
chimerin 2 |
increases expression |
ISO |
Thimerosal results in increased expression of CHN2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 4:83,148,616...83,407,711
Ensembl chr 4:83,147,983...83,407,709
|
|
G |
Chpt1 |
choline phosphotransferase 1 |
increases expression |
ISO |
Thimerosal results in increased expression of CHPT1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 7:22,866,455...22,915,111
Ensembl chr 7:22,863,027...22,915,103
|
|
G |
Cib2 |
calcium and integrin binding family member 2 |
decreases expression |
ISO |
Thimerosal results in decreased expression of CIB2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 8:54,930,265...54,947,157
|
|
G |
Cibar1 |
CBY1 interacting BAR domain containing 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of CIBAR1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 5:25,613,993...25,632,440
Ensembl chr 5:25,614,033...25,632,489
|
|
G |
Cilp2 |
cartilage intermediate layer protein 2 |
decreases expression |
ISO |
Thimerosal results in decreased expression of CILP2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr16:19,539,755...19,547,191
Ensembl chr16:19,539,706...19,547,191
|
|
G |
Cisd2 |
CDGSH iron sulfur domain 2 |
increases expression |
ISO |
Thimerosal results in increased expression of CISD2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 2:223,828,937...223,853,768
Ensembl chr 2:223,828,937...223,868,946
|
|
G |
Cited2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
increases expression |
ISO |
Thimerosal results in increased expression of CITED2 mRNA |
CTD |
PMID:16870260 |
|
NCBI chr 1:12,312,426...12,314,869
Ensembl chr 1:12,312,160...12,314,897
|
|
G |
Clasp2 |
cytoplasmic linker associated protein 2 |
increases expression |
ISO |
Thimerosal results in increased expression of CLASP2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 8:113,677,345...113,859,957
Ensembl chr 8:113,677,284...113,858,731
|
|
G |
Clk4 |
CDC-like kinase 4 |
increases expression |
ISO |
Thimerosal results in increased expression of CLK4 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr10:35,523,382...35,541,387
Ensembl chr10:35,524,755...35,541,352
|
|
G |
Clp1 |
cleavage factor polyribonucleotide kinase subunit 1 |
increases expression |
ISO |
Thimerosal results in increased expression of CLP1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 3:69,806,774...69,818,633
Ensembl chr 3:69,806,778...69,810,421
|
|
G |
Clu |
clusterin |
increases expression decreases expression |
ISO |
Thimerosal results in increased expression of CLU mRNA Thimerosal results in decreased expression of CLU mRNA |
CTD |
PMID:16870260 PMID:27188386 |
|
NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315
|
|
G |
Cmip |
c-Maf-inducing protein |
decreases expression |
ISO |
Thimerosal results in decreased expression of CMIP mRNA |
CTD |
PMID:27188386 |
|
NCBI chr19:45,304,597...45,510,653
Ensembl chr19:45,304,031...45,508,709
|
|
G |
Cnfn |
cornifelin |
decreases expression |
ISO |
Thimerosal results in decreased expression of CNFN mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:80,949,699...80,953,747
Ensembl chr 1:80,951,600...80,953,747
|
|
G |
Cnot7 |
CCR4-NOT transcription complex, subunit 7 |
increases expression |
ISO |
Thimerosal results in increased expression of CNOT7 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr16:51,775,416...51,794,581
Ensembl chr16:51,775,412...51,794,576
|
|
G |
Cnot9 |
CCR4-NOT transcription complex subunit 9 |
increases expression |
ISO |
Thimerosal results in increased expression of CNOT9 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 9:76,084,269...76,109,111
Ensembl chr 9:76,084,334...76,109,100
|
|
G |
Cnpy2 |
canopy FGF signaling regulator 2 |
decreases expression |
ISO |
Thimerosal results in decreased expression of CNPY2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 7:748,877...754,352
Ensembl chr 7:749,008...755,519
|
|
G |
Cntnap2 |
contactin associated protein 2 |
decreases expression |
ISO |
Thimerosal results in decreased expression of CNTNAP2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 4:74,109,455...76,366,434
Ensembl chr 4:74,109,472...76,362,027
|
|
G |
Cobll1 |
cordon-bleu WH2 repeat protein-like 1 |
increases expression |
ISO |
Thimerosal results in increased expression of COBLL1 mRNA |
CTD |
PMID:24675092 |
|
NCBI chr 3:49,753,260...49,915,168
Ensembl chr 3:49,753,262...49,915,194
|
|
G |
Cog3 |
component of oligomeric golgi complex 3 |
increases expression |
ISO |
Thimerosal results in increased expression of COG3 mRNA |
CTD |
PMID:24675092 |
|
NCBI chr15:51,020,808...51,071,288
Ensembl chr15:51,020,813...51,070,570
|
|
G |
Col22a1 |
collagen type XXII alpha 1 chain |
decreases expression |
ISO |
Thimerosal results in decreased expression of COL22A1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 7:103,730,939...103,968,452
Ensembl chr 7:103,731,037...103,968,462
|
|
G |
Col4a6 |
collagen type IV alpha 6 chain |
increases expression |
ISO |
Thimerosal results in increased expression of COL4A6 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr X:104,766,463...105,117,499
Ensembl chr X:104,766,957...105,117,500
|
|
G |
Col9a2 |
collagen type IX alpha 2 chain |
decreases expression |
ISO |
Thimerosal results in decreased expression of COL9A2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 5:134,607,616...134,624,678
Ensembl chr 5:134,607,616...134,624,677
|
|
G |
Cops7b |
COP9 signalosome subunit 7B |
increases expression |
ISO |
Thimerosal results in increased expression of COPS7B mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 9:87,238,132...87,263,967
Ensembl chr 9:87,238,375...87,263,967
|
|
G |
Cox15 |
cytochrome c oxidase assembly homolog COX15 |
decreases expression |
ISO |
Thimerosal results in decreased expression of COX15 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:242,605,588...242,622,279
Ensembl chr 1:242,605,588...242,622,261
|
|
G |
Cox4i1 |
cytochrome c oxidase subunit 4i1 |
increases expression |
ISO |
Thimerosal results in increased expression of COX4I1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr19:48,721,680...48,727,920
Ensembl chr19:48,721,199...48,727,921
|
|
G |
Cpeb2 |
cytoplasmic polyadenylation element binding protein 2 |
multiple interactions increases expression |
ISO |
[NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CPEB2 mRNA Thimerosal results in increased expression of CPEB2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr14:67,787,503...67,839,973
Ensembl chr14:67,787,507...67,840,743
|
|
G |
Cpeb3 |
cytoplasmic polyadenylation element binding protein 3 |
increases expression |
ISO |
Thimerosal results in increased expression of CPEB3 mRNA |
CTD |
PMID:16870260 |
|
NCBI chr 1:234,749,138...234,931,219
Ensembl chr 1:234,751,733...234,931,560
|
|
G |
Cpne3 |
copine 3 |
decreases expression |
ISO |
Thimerosal results in decreased expression of CPNE3 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 5:33,014,658...33,063,934
Ensembl chr 5:33,016,307...33,063,934
|
|
G |
Cps1 |
carbamoyl-phosphate synthase 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of CPS1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 9:68,614,153...68,737,037
Ensembl chr 9:68,614,153...68,737,033
|
|
G |
Crcp |
CGRP receptor component |
decreases expression |
ISO |
Thimerosal results in decreased expression of CRCP mRNA |
CTD |
PMID:27188386 |
|
NCBI chr12:26,623,968...26,659,756
Ensembl chr12:26,623,976...26,768,225
|
|
G |
Creb1 |
cAMP responsive element binding protein 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of CREB1 mRNA |
CTD |
PMID:24675092 |
|
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
|
|
G |
Crip3 |
cysteine-rich protein 3 |
decreases expression |
ISO |
Thimerosal results in decreased expression of CRIP3 mRNA |
CTD |
PMID:24675092 |
|
NCBI chr 9:14,554,450...14,557,344
Ensembl chr 9:14,554,450...14,557,302
|
|
G |
Cryab |
crystallin, alpha B |
increases expression |
ISO |
Thimerosal results in increased expression of CRYAB mRNA |
CTD |
PMID:16870260 |
|
NCBI chr 8:51,093,441...51,099,161
Ensembl chr 8:51,093,441...51,099,157
|
|
G |
Cs |
citrate synthase |
decreases expression |
ISO |
Thimerosal results in decreased expression of CS mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 7:758,074...791,421
Ensembl chr 7:758,345...791,421
|
|
G |
Cspp1 |
centrosome and spindle pole associated protein 1 |
increases expression |
ISO |
Thimerosal results in increased expression of CSPP1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 5:9,077,161...9,192,402
Ensembl chr 5:9,077,161...9,193,377
|
|
G |
Ctdspl2 |
CTD small phosphatase like 2 |
increases expression |
ISO |
Thimerosal results in increased expression of CTDSPL2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 3:108,915,263...108,970,620
Ensembl chr 3:108,915,280...108,967,227
|
|
G |
Ctnna1 |
catenin alpha 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of CTNNA1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr18:26,728,246...26,860,911
Ensembl chr18:26,728,485...26,860,910
|
|
G |
Ctxn3 |
cortexin 3 |
increases expression |
ISO |
Thimerosal results in increased expression of CTXN3 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr18:50,930,244...50,940,642
Ensembl chr18:50,930,235...50,940,641
|
|
G |
Cxhxorf38 |
similar to human chromosome X open reading frame 38 |
decreases expression |
ISO |
Thimerosal results in decreased expression of CXORF38 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr X:10,128,070...10,150,904
Ensembl chr X:10,129,657...10,150,900
|
|
G |
Cyb5r3 |
cytochrome b5 reductase 3 |
decreases expression |
ISO |
Thimerosal results in decreased expression of CYB5R3 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 7:114,306,686...114,324,247
Ensembl chr 7:114,306,685...114,324,298
|
|
G |
Cyb5r4 |
cytochrome b5 reductase 4 |
increases expression |
ISO |
Thimerosal results in increased expression of CYB5R4 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 8:87,975,596...88,048,356
Ensembl chr 8:87,981,116...88,045,832
|
|
G |
Cyp39a1 |
cytochrome P450, family 39, subfamily a, polypeptide 1 |
increases expression |
ISO |
Thimerosal results in increased expression of CYP39A1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 9:17,230,455...17,306,775
Ensembl chr 9:17,230,455...17,306,775
|
|
G |
Dact3 |
dishevelled-binding antagonist of beta-catenin 3 |
decreases expression |
ISO |
Thimerosal results in decreased expression of DACT3 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:77,546,900...77,558,631
Ensembl chr 1:77,546,900...77,558,630
|
|
G |
Dbh |
dopamine beta-hydroxylase |
multiple interactions |
ISO |
[Thimerosal co-treated with Aluminum Hydroxide] results in increased expression of DBH protein |
CTD |
PMID:36411272 |
|
NCBI chr 3:10,488,260...10,505,245
Ensembl chr 3:10,488,260...10,505,248
|
|
G |
Dbn1 |
drebrin 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of DBN1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr17:9,150,608...9,164,982
Ensembl chr17:9,150,659...9,164,984
|
|
G |
Dcaf13 |
DDB1 and CUL4 associated factor 13 |
increases expression |
ISO |
Thimerosal results in increased expression of DCAF13 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 7:70,160,983...70,196,142
Ensembl chr 7:70,160,941...70,196,142
|
|
G |
Dcaf16 |
DDB1 and CUL4 associated factor 16 |
decreases expression |
ISO |
Thimerosal results in decreased expression of DCAF16 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr14:65,449,631...65,450,015
|
|
G |
Dcaf4 |
DDB1 and CUL4 associated factor 4 |
decreases expression |
ISO |
Thimerosal results in decreased expression of DCAF4 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 6:103,154,847...103,180,992
Ensembl chr 6:103,154,867...103,180,982
|
|
G |
Dcaf7 |
DDB1 and CUL4 associated factor 7 |
decreases expression |
ISO |
Thimerosal results in decreased expression of DCAF7 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr10:90,974,095...90,996,275
Ensembl chr10:90,974,095...90,996,275
|
|
G |
Dcc |
DCC netrin 1 receptor |
increases expression |
ISO |
Thimerosal results in increased expression of DCC mRNA |
CTD |
PMID:27188386 |
|
NCBI chr18:64,868,987...65,972,783
Ensembl chr18:64,873,898...65,972,740
|
|
G |
Dcun1d1 |
defective in cullin neddylation 1 domain containing 1 |
increases expression |
ISO |
Thimerosal results in increased expression of DCUN1D1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 2:118,721,275...118,772,606
Ensembl chr 2:118,721,822...118,772,602
|
|
G |
Dcx |
doublecortin |
increases expression |
ISO |
Thimerosal results in increased expression of DCX mRNA |
CTD |
PMID:24675092 |
|
NCBI chr X:107,430,767...107,573,612
Ensembl chr X:107,430,767...107,507,476
|
|
G |
Ddx39b |
DExD-box helicase 39B |
decreases expression |
ISO |
Thimerosal results in decreased expression of DDX39B mRNA |
CTD |
PMID:27188386 |
|
NCBI chr20:3,547,702...3,585,064
Ensembl chr20:3,572,056...3,584,996
|
|
G |
Ddx6 |
DEAD-box helicase 6 |
decreases expression |
ISO |
Thimerosal results in decreased expression of DDX6 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 8:44,931,127...44,967,773
Ensembl chr 8:44,931,974...44,964,405
|
|
G |
Dennd1b |
DENN domain containing 1B |
increases expression |
ISO |
Thimerosal results in increased expression of DENND1B mRNA |
CTD |
PMID:27188386 |
|
NCBI chr13:50,545,324...50,772,922
Ensembl chr13:50,545,836...50,770,601
|
|
G |
Dexi |
Dexi homolog |
decreases expression |
ISO |
Thimerosal results in decreased expression of DEXI mRNA |
CTD |
PMID:27188386 |
|
NCBI chr10:5,126,021...5,138,746
Ensembl chr10:5,137,288...5,138,738
|
|
G |
Dgat1 |
diacylglycerol O-acyltransferase 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of DGAT1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 7:108,223,860...108,235,413
Ensembl chr 7:108,218,524...108,234,299
|
|
G |
Dhcr24 |
24-dehydrocholesterol reductase |
decreases expression |
ISO |
Thimerosal results in decreased expression of DHCR24 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 5:121,344,552...121,371,124
Ensembl chr 5:121,344,575...121,371,137
|
|
G |
Dhcr7 |
7-dehydrocholesterol reductase |
decreases expression |
ISO |
Thimerosal results in decreased expression of DHCR7 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:199,015,081...199,031,055
Ensembl chr 1:199,015,081...199,031,055
|
|
G |
Dhrs1 |
dehydrogenase/reductase 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of DHRS1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr15:29,236,522...29,243,807
Ensembl chr15:29,236,522...29,243,838
|
|
G |
Dhx36 |
DEAH-box helicase 36 |
increases expression |
ISO |
Thimerosal results in increased expression of DHX36 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 2:146,856,469...146,894,577
Ensembl chr 2:146,856,469...146,894,572
|
|
G |
Dhx9 |
DExH-box helicase 9 |
decreases expression |
ISO |
Thimerosal results in decreased expression of DHX9 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr13:65,602,322...65,639,098
Ensembl chr13:65,602,323...65,639,069
|
|
G |
Dkkl1 |
dickkopf like acrosomal protein 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of DKKL1 mRNA |
CTD |
PMID:24675092 |
|
NCBI chr 1:95,694,010...95,699,259
Ensembl chr 1:95,694,010...95,699,259
|
|
G |
Dlg1 |
discs large MAGUK scaffold protein 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of DLG1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr11:68,911,883...69,103,230
Ensembl chr11:68,911,883...69,102,689
|
|
G |
Dnajb1 |
DnaJ heat shock protein family (Hsp40) member B1 |
increases expression |
ISO |
Thimerosal results in increased expression of DNAJB1 mRNA |
CTD |
PMID:16870260 |
|
NCBI chr19:24,522,731...24,526,419
Ensembl chr19:24,522,717...24,526,458
|
|
G |
Dnajb4 |
DnaJ heat shock protein family (Hsp40) member B4 |
increases expression |
ISO |
Thimerosal results in increased expression of DNAJB4 mRNA |
CTD |
PMID:16870260 |
|
NCBI chr 2:241,129,346...241,159,272
Ensembl chr 2:241,130,340...241,159,089
|
|
G |
Dnajc13 |
DnaJ heat shock protein family (Hsp40) member C13 |
decreases expression |
ISO |
Thimerosal results in decreased expression of DNAJC13 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 8:104,767,785...104,877,317
Ensembl chr 8:104,767,788...104,877,317
|
|
G |
Dnajc4 |
DnaJ heat shock protein family (Hsp40) member C4 |
decreases expression |
ISO |
Thimerosal results in decreased expression of DNAJC4 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:204,178,189...204,182,412
Ensembl chr 1:204,178,191...204,182,387
|
|
G |
Dnase1 |
deoxyribonuclease 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of DNASE1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr10:11,498,930...11,505,151
Ensembl chr10:11,498,931...11,501,869
|
|
G |
Dnmt3a |
DNA methyltransferase 3 alpha |
decreases expression |
ISO |
Thimerosal results in decreased expression of DNMT3A mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 6:26,791,517...26,902,161
Ensembl chr 6:26,822,609...26,896,687
|
|
G |
Dock11 |
dedicator of cytokinesis 11 |
decreases expression |
ISO |
Thimerosal results in decreased expression of DOCK11 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr X:115,131,720...115,314,854
Ensembl chr X:115,131,909...115,314,854
|
|
G |
Dock4 |
dedicator of cytokinesis 4 |
increases expression |
ISO |
Thimerosal results in increased expression of DOCK4 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 6:57,512,929...57,902,597
Ensembl chr 6:57,512,908...57,901,855
|
|
G |
Dock6 |
dedicator of cytokinesis 6 |
decreases expression |
ISO |
Thimerosal results in decreased expression of DOCK6 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 8:20,342,430...20,394,660
Ensembl chr 8:20,342,089...20,394,552
|
|
G |
Dst |
dystonin |
affects expression |
ISO |
Thimerosal affects the expression of DST mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 9:36,135,657...36,529,617
Ensembl chr 9:36,135,284...36,529,615
|
|
G |
Dusp1 |
dual specificity phosphatase 1 |
increases expression |
ISO |
Thimerosal results in increased expression of DUSP1 mRNA |
CTD |
PMID:16870260 |
|
NCBI chr10:16,680,478...16,683,275
|
|
G |
Dusp7 |
dual specificity phosphatase 7 |
decreases expression |
ISO |
Thimerosal results in decreased expression of DUSP7 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 8:107,009,369...107,016,404
Ensembl chr 8:107,008,528...107,016,404
|
|
G |
Dynlt2b |
dynein light chain Tctex-type 2B |
increases expression |
ISO |
Thimerosal results in increased expression of DYNLT2B mRNA |
CTD |
PMID:27188386 |
|
NCBI chr11:68,359,138...68,367,573
Ensembl chr11:68,358,263...68,367,499
|
|
G |
Echdc2 |
enoyl CoA hydratase domain containing 2 |
decreases expression |
ISO |
Thimerosal results in decreased expression of ECHDC2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 5:122,915,874...122,934,860
Ensembl chr 5:122,916,134...122,934,859
|
|
G |
Ecrg4 |
ECRG4 augurin precursor |
decreases expression |
ISO |
Thimerosal results in decreased expression of ECRG4 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 9:45,992,954...46,012,605
Ensembl chr 9:45,992,954...46,012,595
|
|
G |
Ednrb |
endothelin receptor type B |
decreases expression |
ISO |
Thimerosal results in decreased expression of EDNRB mRNA |
CTD |
PMID:27188386 |
|
NCBI chr15:80,640,839...80,672,115
Ensembl chr15:80,643,043...80,672,115
|
|
G |
Eea1 |
early endosome antigen 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of EEA1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 7:30,554,686...30,722,186
Ensembl chr 7:30,554,552...30,718,487
|
|
G |
Eef1a2 |
eukaryotic translation elongation factor 1 alpha 2 |
decreases expression |
ISO |
Thimerosal results in decreased expression of EEF1A2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 3:168,265,893...168,275,071
Ensembl chr 3:168,195,357...168,275,071
|
|
G |
Eef1akmt3 |
EEF1A lysine methyltransferase 3 |
decreases expression |
ISO |
Thimerosal results in decreased expression of EEF1AKMT3 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 7:62,853,304...62,864,558
Ensembl chr 7:62,854,899...62,864,617
|
|
G |
Efcab14 |
EF-hand calcium binding domain 14 |
decreases expression |
ISO |
Thimerosal results in decreased expression of EFCAB14 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 5:129,218,139...129,258,628
Ensembl chr 5:129,218,424...129,258,625
|
|
G |
Egfl7 |
EGF-like-domain, multiple 7 |
decreases expression |
ISO |
Thimerosal results in decreased expression of EGFL7 mRNA |
CTD |
PMID:24675092 PMID:27188386 |
|
NCBI chr 3:9,404,622...9,416,879
Ensembl chr 3:9,407,520...9,416,879
|
|
G |
Egln1 |
egl-9 family hypoxia-inducible factor 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of EGLN1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr19:52,867,900...52,907,308
Ensembl chr19:52,869,486...52,907,777
|
|
G |
Egln3 |
egl-9 family hypoxia-inducible factor 3 |
decreases expression |
ISO |
Thimerosal results in decreased expression of EGLN3 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 6:71,650,297...71,675,766
Ensembl chr 6:71,650,297...71,675,766
|
|
G |
Ehbp1 |
EH domain binding protein 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of EHBP1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr14:96,093,327...96,380,502
Ensembl chr14:96,093,327...96,345,332
|
|
G |
Ehd4 |
EH-domain containing 4 |
decreases expression |
ISO |
Thimerosal results in decreased expression of EHD4 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 3:107,058,191...107,121,985
Ensembl chr 3:107,058,958...107,122,002
|
|
G |
Ehmt1 |
euchromatic histone lysine methyltransferase 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of EHMT1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 3:7,580,680...7,729,046
Ensembl chr 3:7,580,683...7,729,007
|
|
G |
Eif3f |
eukaryotic translation initiation factor 3, subunit F |
decreases expression |
ISO |
Thimerosal results in decreased expression of EIF3F mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:162,934,220...162,943,204
Ensembl chr 1:162,934,212...162,943,204
|
|
G |
Eif4b |
eukaryotic translation initiation factor 4B |
decreases expression |
ISO |
Thimerosal results in decreased expression of EIF4B mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 7:133,206,637...133,228,436
|
|
G |
Eif4g1 |
eukaryotic translation initiation factor 4 gamma 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of EIF4G1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr11:80,221,919...80,241,958
Ensembl chr11:80,221,919...80,241,941
|
|
G |
Eif5a2 |
eukaryotic translation initiation factor 5A2 |
decreases expression |
ISO |
Thimerosal results in decreased expression of EIF5A2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 2:111,728,587...111,746,087
Ensembl chr 2:111,729,323...111,746,087
|
|
G |
Elac1 |
elaC ribonuclease Z 1 |
increases expression |
ISO |
Thimerosal results in increased expression of ELAC1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr18:67,321,231...67,341,358
Ensembl chr18:67,323,583...67,340,936
|
|
G |
Elmo1 |
engulfment and cell motility 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of ELMO1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr17:44,286,495...44,822,668
Ensembl chr17:44,286,485...44,822,788
|
|
G |
Eloa |
elongin A |
decreases expression |
ISO |
Thimerosal results in decreased expression of ELOA mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 5:148,231,600...148,246,760
Ensembl chr 5:148,231,596...148,246,765
|
|
G |
Eml5 |
EMAP like 5 |
increases expression |
ISO |
Thimerosal results in increased expression of EML5 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 6:118,046,655...118,175,831
Ensembl chr 6:118,046,655...118,175,831
|
|
G |
Eno1 |
enolase 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of ENO1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 5:160,719,951...160,731,337
Ensembl chr 5:160,719,951...160,731,336
|
|
G |
Eno2 |
enolase 2 |
decreases expression |
ISO |
Thimerosal results in decreased expression of ENO2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 4:157,572,085...157,580,971
Ensembl chr 4:157,572,088...157,580,980
|
|
G |
Eno3 |
enolase 3 |
decreases expression |
ISO |
Thimerosal results in decreased expression of ENO3 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr10:55,370,531...55,375,921
Ensembl chr10:55,366,975...55,375,921
|
|
G |
Enpp5 |
ectonucleotide pyrophosphatase/phosphodiesterase family member 5 |
decreases expression |
ISO |
Thimerosal results in decreased expression of ENPP5 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 9:16,910,187...16,917,633
Ensembl chr 9:16,910,831...16,917,480
|
|
G |
Ep400 |
E1A binding protein p400 |
decreases expression |
ISO |
Thimerosal results in decreased expression of EP400 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr12:45,891,886...46,002,523
Ensembl chr12:45,891,916...45,998,861
|
|
G |
Epb41l1 |
erythrocyte membrane protein band 4.1-like 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of EPB41L1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 3:144,929,195...145,052,723
Ensembl chr 3:144,984,640...145,052,721
|
|
G |
Epb41l4a |
erythrocyte membrane protein band 4.1 like 4A |
decreases expression |
ISO |
Thimerosal results in decreased expression of EPB41L4A mRNA |
CTD |
PMID:27188386 |
|
NCBI chr18:25,405,461...25,615,392
Ensembl chr18:25,406,057...25,615,149
|
|
G |
Epb41l5 |
erythrocyte membrane protein band 4.1 like 5 |
decreases expression |
ISO |
Thimerosal results in decreased expression of EPB41L5 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr13:30,670,792...30,770,213
Ensembl chr13:30,669,764...30,768,360
|
|
G |
Epc1 |
enhancer of polycomb homolog 1 |
increases expression |
ISO |
Thimerosal results in increased expression of EPC1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr17:54,503,358...54,594,444
Ensembl chr17:54,503,358...54,594,425
|
|
G |
Epcam |
epithelial cell adhesion molecule |
increases expression |
ISO |
Thimerosal results in increased expression of EPCAM mRNA |
CTD |
PMID:24675092 |
|
NCBI chr 6:6,880,142...6,896,103
Ensembl chr 6:6,878,237...6,896,127
|
|
G |
Epop |
elongin BC and polycomb repressive complex 2 associated protein |
decreases expression |
ISO |
Thimerosal results in decreased expression of EPOP mRNA |
CTD |
PMID:27188386 |
|
NCBI chr10:82,624,392...82,625,912
Ensembl chr10:82,624,392...82,625,912
|
|
G |
Eprs1 |
glutamyl-prolyl-tRNA synthetase 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of EPRS1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr13:96,901,548...96,971,966
Ensembl chr13:96,901,575...96,971,966
|
|
G |
Erc1 |
ELKS/RAB6-interacting/CAST family member 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of ERC1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 4:152,763,664...153,055,724
Ensembl chr 4:152,767,419...153,055,639
|
|
G |
Ercc2 |
ERCC excision repair 2, TFIIH core complex helicase subunit |
decreases expression |
ISO |
Thimerosal results in decreased expression of ERCC2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:79,033,342...79,047,102
Ensembl chr 1:79,033,326...79,047,102
|
|
G |
Ergic1 |
endoplasmic reticulum-golgi intermediate compartment 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of ERGIC1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr10:16,531,192...16,626,974
Ensembl chr10:16,531,194...16,626,957
|
|
G |
Ergic2 |
ERGIC and golgi 2 |
increases expression |
ISO |
Thimerosal results in increased expression of ERGIC2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 4:181,090,808...181,123,074
Ensembl chr 4:181,090,808...181,123,060
|
|
G |
Esco1 |
establishment of sister chromatid cohesion N-acetyltransferase 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of ESCO1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr18:1,630,560...1,686,803
Ensembl chr18:1,631,954...1,686,942
|
|
G |
Esco2 |
establishment of sister chromatid cohesion N-acetyltransferase 2 |
decreases expression |
ISO |
Thimerosal results in decreased expression of ESCO2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr15:40,034,566...40,052,295
Ensembl chr15:40,034,568...40,055,306
|
|
G |
Esf1 |
ESF1 nucleolar pre-rRNA processing protein homolog |
increases expression |
ISO |
Thimerosal results in increased expression of ESF1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 3:127,454,744...127,507,941
Ensembl chr 3:127,454,811...127,507,817
|
|
G |
Etnk1 |
ethanolamine kinase 1 |
increases expression |
ISO |
Thimerosal results in increased expression of ETNK1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 4:176,126,056...176,170,325
Ensembl chr 4:176,126,180...176,193,770
|
|
G |
Evc2 |
EvC ciliary complex subunit 2 |
decreases expression |
ISO |
Thimerosal results in decreased expression of EVC2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr14:73,366,832...73,454,539
Ensembl chr14:73,367,963...73,454,516
|
|
G |
Evi5 |
ecotropic viral integration site 5 |
decreases expression |
ISO |
Thimerosal results in decreased expression of EVI5 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr14:1,875,601...2,021,678
Ensembl chr14:1,875,647...2,021,678
|
|
G |
Exoc6 |
exocyst complex component 6 |
increases expression |
ISO |
Thimerosal results in increased expression of EXOC6 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:235,314,612...235,457,824
Ensembl chr 1:235,300,369...235,457,015
|
|
G |
F12 |
coagulation factor XII |
decreases expression |
ISO |
Thimerosal results in decreased expression of F12 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr17:9,207,683...9,215,530
Ensembl chr17:9,207,683...9,215,530
|
|
G |
Fabp7 |
fatty acid binding protein 7 |
increases expression |
ISO |
Thimerosal results in increased expression of FABP7 mRNA |
CTD |
PMID:24675092 |
|
NCBI chr20:37,123,193...37,126,725
Ensembl chr20:37,123,193...37,126,880
|
|
G |
Fads1 |
fatty acid desaturase 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of FADS1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:206,827,724...206,842,734
Ensembl chr 1:206,827,765...206,842,734
|
|
G |
Fads2 |
fatty acid desaturase 2 |
decreases expression |
ISO |
Thimerosal results in decreased expression of FADS2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:206,707,384...206,747,333
Ensembl chr 1:206,708,783...206,748,789
|
|
G |
Faf2 |
Fas associated factor family member 2 |
decreases expression |
ISO |
Thimerosal results in decreased expression of FAF2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr17:9,947,211...9,989,474
Ensembl chr17:9,947,220...9,989,485
|
|
G |
Fah |
fumarylacetoacetate hydrolase |
decreases expression |
ISO |
Thimerosal results in decreased expression of FAH mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:138,548,830...138,571,599
Ensembl chr 1:138,548,834...138,571,505
|
|
G |
Fam124b |
family with sequence similarity 124 member B |
decreases expression |
ISO |
Thimerosal results in decreased expression of FAM124B mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 9:81,513,018...81,533,621
Ensembl chr 9:81,515,399...81,533,341
|
|
G |
Fam135a |
family with sequence similarity 135, member A |
affects expression |
ISO |
Thimerosal affects the expression of FAM135A mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 9:26,420,116...26,500,803
Ensembl chr 9:26,420,528...26,500,717
|
|
G |
Fam149a |
family with sequence similarity 149, member A |
decreases expression |
ISO |
Thimerosal results in decreased expression of FAM149A mRNA |
CTD |
PMID:27188386 |
|
NCBI chr16:46,855,377...46,914,553
Ensembl chr16:46,854,635...46,912,066
|
|
G |
Fam162a |
family with sequence similarity 162, member A |
decreases expression |
ISO |
Thimerosal results in decreased expression of FAM162A mRNA |
CTD |
PMID:27188386 |
|
NCBI chr11:64,680,978...64,709,865
Ensembl chr11:64,680,323...64,711,239
|
|
G |
Fam168b |
family with sequence similarity 168, member B |
decreases expression |
ISO |
Thimerosal results in decreased expression of FAM168B mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 9:37,005,569...37,038,631
Ensembl chr 9:37,006,689...37,033,723
|
|
G |
Fam234b |
family with sequence similarity 234, member B |
decreases expression |
ISO |
Thimerosal results in decreased expression of FAM234B mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 4:168,048,313...168,124,017
Ensembl chr 4:168,048,396...168,097,338
|
|
G |
Fam3c |
FAM3 metabolism regulating signaling molecule C |
increases expression |
ISO |
Thimerosal results in increased expression of FAM3C mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 4:50,839,929...50,887,276
Ensembl chr 4:50,838,818...50,888,078
|
|
G |
Fam76b |
family with sequence similarity 76, member B |
increases expression |
ISO |
Thimerosal results in increased expression of FAM76B mRNA |
CTD |
PMID:24675092 |
|
NCBI chr 8:10,689,396...10,711,847
Ensembl chr 8:10,688,963...10,711,861
|
|
G |
Fam81b |
family with sequence similarity 81, member B |
increases expression |
ISO |
Thimerosal results in increased expression of FAM81B mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 2:5,750,678...5,870,580
Ensembl chr 2:5,771,240...5,879,440
|
|
G |
Fancf |
FA complementation group F |
decreases expression |
ISO |
Thimerosal results in decreased expression of FANCF mRNA |
CTD |
PMID:16870260 |
|
NCBI chr 1:101,449,120...101,451,936
Ensembl chr 1:101,450,389...101,451,923
|
|
G |
Fas |
Fas cell surface death receptor |
increases expression |
ISO |
Thimerosal results in increased expression of FAS mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Fasn |
fatty acid synthase |
decreases expression |
ISO |
Thimerosal results in decreased expression of FASN mRNA |
CTD |
PMID:27188386 |
|
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
|
|
G |
Fastkd2 |
FAST kinase domains 2 |
increases expression |
ISO |
Thimerosal results in increased expression of FASTKD2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 9:65,166,148...65,188,184
Ensembl chr 9:65,168,228...65,188,174
|
|
G |
Fbln2 |
fibulin 2 |
decreases expression |
ISO |
Thimerosal results in decreased expression of FBLN2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 4:123,704,289...123,763,857
Ensembl chr 4:123,704,373...123,763,948
|
|
G |
Fbn1 |
fibrillin 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of FBN1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 3:112,554,257...112,750,835
Ensembl chr 3:112,554,925...112,750,889
|
|
G |
Fbxo3 |
F-box protein 3 |
increases expression |
ISO |
Thimerosal results in increased expression of FBXO3 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 3:90,417,262...90,449,557
Ensembl chr 3:90,417,297...90,449,557
|
|
G |
Fbxo7 |
F-box protein 7 |
decreases expression |
ISO |
Thimerosal results in decreased expression of FBXO7 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 7:17,809,224...17,837,549
Ensembl chr 7:17,809,231...17,837,530
|
|
G |
Fbxo9 |
f-box protein 9 |
increases expression |
ISO |
Thimerosal results in increased expression of FBXO9 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 8:78,958,482...78,984,015
Ensembl chr 8:78,958,483...78,983,949
|
|
G |
Fer |
FER tyrosine kinase |
increases expression |
ISO |
Thimerosal results in increased expression of FER mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 9:103,520,452...103,827,364
Ensembl chr 9:103,520,493...103,821,451
|
|
G |
Fer1l4 |
fer-1-like family member 4 |
decreases expression |
ISO |
Thimerosal results in decreased expression of FER1L4 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 3:144,536,099...144,571,634
Ensembl chr 3:144,536,099...144,571,634
|
|
G |
Fgd6 |
FYVE, RhoGEF and PH domain containing 6 |
increases expression |
ISO |
Thimerosal results in increased expression of FGD6 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 7:28,597,609...28,712,908
Ensembl chr 7:28,597,609...28,712,456
|
|
G |
Fgf11 |
fibroblast growth factor 11 |
decreases expression |
ISO |
Thimerosal results in decreased expression of FGF11 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr10:54,516,508...54,522,067
Ensembl chr10:54,517,077...54,522,062
|
|
G |
Fgfbp3 |
fibroblast growth factor binding protein 3 |
decreases expression |
ISO |
Thimerosal results in decreased expression of FGFBP3 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:234,644,023...234,646,028
Ensembl chr 1:234,644,019...234,646,547
|
|
G |
Fgfr1op2 |
FGFR1 oncogene partner 2 |
increases expression |
ISO |
Thimerosal results in increased expression of FGFR1OP2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 4:179,491,602...179,512,630
Ensembl chr 4:179,491,599...179,512,630
|
|
G |
Fgfr2 |
fibroblast growth factor receptor 2 |
decreases expression |
ISO |
Thimerosal results in decreased expression of FGFR2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:184,745,418...184,850,655
Ensembl chr 1:184,745,420...184,850,626
|
|
G |
Fkbp10 |
FKBP prolyl isomerase 10 |
decreases expression |
ISO |
Thimerosal results in decreased expression of FKBP10 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr10:85,345,434...85,357,998
Ensembl chr10:85,346,126...85,427,330
|
|
G |
Flcn |
folliculin |
multiple interactions |
ISO |
[NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FLCN mRNA |
CTD |
PMID:27188386 |
|
NCBI chr10:44,588,621...44,607,808
Ensembl chr10:44,588,624...44,607,769
|
|
G |
Fmnl2 |
formin-like 2 |
decreases expression |
ISO |
Thimerosal results in decreased expression of FMNL2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 3:37,348,791...37,624,746
Ensembl chr 3:37,348,574...37,624,754
|
|
G |
Fn1 |
fibronectin 1 |
increases secretion |
ISO |
Thimerosal results in increased secretion of FN1 protein |
CTD |
PMID:24942245 |
|
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
|
|
G |
Fnbp4 |
formin binding protein 4 |
decreases expression |
ISO |
Thimerosal results in decreased expression of FNBP4 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 3:76,733,012...76,763,077
Ensembl chr 3:76,733,027...76,763,079
|
|
G |
Fndc10 |
fibronectin type III domain containing 10 |
decreases expression |
ISO |
Thimerosal results in decreased expression of FNDC10 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 5:166,299,587...166,311,477
Ensembl chr 5:166,300,122...166,310,326
|
|
G |
Fndc11 |
fibronectin type III domain containing 11 |
decreases expression |
ISO |
Thimerosal results in decreased expression of FNDC11 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 3:168,330,607...168,333,111
Ensembl chr 3:168,330,602...168,334,617
|
|
G |
Fndc4 |
fibronectin type III domain containing 4 |
decreases expression |
ISO |
Thimerosal results in decreased expression of FNDC4 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 6:25,077,155...25,080,812
Ensembl chr 6:25,077,349...25,080,675
|
|
G |
Folr1 |
folate receptor alpha |
decreases expression |
ISO |
Thimerosal results in decreased expression of FOLR1 mRNA |
CTD |
PMID:24675092 |
|
NCBI chr 1:156,219,460...156,238,436
Ensembl chr 1:156,219,460...156,230,667
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
increases expression |
ISO |
Thimerosal results in increased expression of FOS mRNA |
CTD |
PMID:16870260 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Fosb |
FosB proto-oncogene, AP-1 transcription factor subunit |
increases expression |
ISO |
Thimerosal results in increased expression of FOSB mRNA |
CTD |
PMID:16870260 |
|
NCBI chr 1:78,954,312...78,961,492
Ensembl chr 1:78,954,115...78,961,465
|
|
G |
Foxc1 |
forkhead box C1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of FOXC1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr17:32,631,379...32,635,361
Ensembl chr17:32,633,142...32,634,803
|
|
G |
Foxp2 |
forkhead box P2 |
increases expression |
ISO |
Thimerosal results in increased expression of FOXP2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 4:43,133,827...43,712,442
Ensembl chr 4:43,133,912...43,711,683
|
|
G |
Fra10ac1 |
FRA10A associated CGG repeat 1 |
multiple interactions |
ISO |
[NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FRA10AC1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:235,969,071...236,001,074
Ensembl chr 1:235,969,112...236,001,210
|
|
G |
Frmd7 |
FERM domain containing 7 |
increases expression |
ISO |
Thimerosal results in increased expression of FRMD7 mRNA |
CTD |
PMID:24675092 |
|
NCBI chr X:130,375,925...130,423,836
Ensembl chr X:130,377,227...130,423,771
|
|
G |
Frmpd3 |
FERM and PDZ domain containing 3 |
increases expression |
ISO |
Thimerosal results in increased expression of FRMPD3 mRNA |
CTD |
PMID:24675092 |
|
NCBI chr X:103,964,168...104,113,864
Ensembl chr X:104,043,194...104,111,968
|
|
G |
Frs2 |
fibroblast growth factor receptor substrate 2 |
increases expression |
ISO |
Thimerosal results in increased expression of FRS2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 7:52,711,255...52,792,738
Ensembl chr 7:52,711,257...52,792,743
|
|
G |
Fshb |
follicle stimulating hormone subunit beta |
increases expression |
ISO |
Thimerosal results in increased expression of FSHB mRNA; Thimerosal results in increased expression of FSHB protein |
CTD |
PMID:24675092 |
|
NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370
|
|
G |
Fsip2 |
fibrous sheath-interacting protein 2 |
increases expression |
ISO |
Thimerosal results in increased expression of FSIP2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 3:67,962,345...68,032,866
Ensembl chr 3:67,962,360...68,032,868
|
|
G |
Fut1 |
fucosyltransferase 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of FUT1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:96,086,934...96,090,352
Ensembl chr 1:96,086,635...96,090,616
|
|
G |
Fut11 |
fucosyltransferase 11 |
decreases expression |
ISO |
Thimerosal results in decreased expression of FUT11 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr15:3,598,768...3,602,328
Ensembl chr15:3,598,758...3,602,356
|
|
G |
Fxyd6 |
FXYD domain-containing ion transport regulator 6 |
decreases expression |
ISO |
Thimerosal results in decreased expression of FXYD6 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 8:45,679,054...45,705,958
Ensembl chr 8:45,678,885...45,705,958
|
|
G |
Fzd2 |
frizzled class receptor 2 |
decreases expression |
ISO |
Thimerosal results in decreased expression of FZD2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr10:87,561,866...87,563,776
Ensembl chr10:87,561,326...87,565,334
|
|
G |
Fzd7 |
frizzled class receptor 7 |
decreases expression |
ISO |
Thimerosal results in decreased expression of FZD7 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 9:60,931,433...60,934,252
Ensembl chr 9:60,930,875...60,935,781
|
|
G |
G3bp1 |
G3BP stress granule assembly factor 1 |
affects expression |
ISO |
Thimerosal affects the expression of G3BP1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr10:39,586,864...39,620,268
Ensembl chr10:39,586,864...39,620,268
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
decreases expression |
ISO |
Thimerosal results in decreased expression of G6PD mRNA |
CTD |
PMID:27188386 |
|
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
|
|
G |
Gabra1 |
gamma-aminobutyric acid type A receptor subunit alpha 1 |
increases expression |
ISO |
Thimerosal results in increased expression of GABRA1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr10:26,595,151...26,650,611
Ensembl chr10:26,595,160...26,650,864
|
|
G |
Gabrr1 |
gamma-aminobutyric acid type A receptor subunit rho 1 |
increases expression |
ISO |
Thimerosal results in increased expression of GABRR1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 5:47,524,151...47,561,228
Ensembl chr 5:47,524,151...47,561,228
|
|
G |
Gadd45g |
growth arrest and DNA-damage-inducible, gamma |
increases expression |
ISO |
Thimerosal results in increased expression of GADD45G mRNA |
CTD |
PMID:16870260 |
|
NCBI chr17:13,376,842...13,378,587
Ensembl chr17:13,376,839...13,378,610
|
|
G |
Gapvd1 |
GTPase activating protein and VPS9 domains 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of GAPVD1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 3:17,968,345...18,041,888
Ensembl chr 3:17,969,599...18,055,218
|
|
G |
Garem1 |
GRB2 associated regulator of MAPK1 subtype 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of GAREM1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr18:12,420,169...12,585,323
Ensembl chr18:12,423,882...12,585,345
|
|
G |
Garem2 |
GRB2 associated regulator of MAPK1 subtype 2 |
decreases expression |
ISO |
Thimerosal results in decreased expression of GAREM2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 6:26,228,965...26,255,576
Ensembl chr 6:26,230,048...26,241,762
|
|
G |
Gas2l1 |
growth arrest-specific 2 like 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of GAS2L1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr14:79,955,350...79,961,830
Ensembl chr14:79,950,555...79,961,438
|
|
G |
Gbe1 |
1,4-alpha-glucan branching enzyme 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of GBE1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr11:8,734,806...9,000,226
Ensembl chr11:8,734,820...9,000,210
|
|
G |
Gemin4 |
gem (nuclear organelle) associated protein 4 |
decreases expression |
ISO |
Thimerosal results in decreased expression of GEMIN4 mRNA |
CTD |
PMID:16870260 |
|
NCBI chr10:61,062,420...61,073,529
Ensembl chr10:61,066,425...61,073,431 Ensembl chr10:61,066,425...61,073,431
|
|
G |
Gfm1 |
G elongation factor, mitochondrial 1 |
increases expression |
ISO |
Thimerosal results in increased expression of GFM1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 2:151,700,573...151,745,477
Ensembl chr 2:151,700,564...151,745,471
|
|
G |
Gh1 |
growth hormone 1 |
increases expression |
ISO |
Thimerosal results in increased expression of GH mRNA |
CTD |
PMID:24675092 |
|
NCBI chr10:91,228,102...91,230,079
Ensembl chr10:91,228,103...91,230,078
|
|
G |
Ghrhr |
growth hormone releasing hormone receptor |
increases expression |
ISO |
Thimerosal results in increased expression of GHRHR mRNA |
CTD |
PMID:24675092 |
|
NCBI chr 4:84,498,159...84,532,851
Ensembl chr 4:84,500,212...84,532,776
|
|
G |
Gigyf1 |
GRB10 interacting GYF protein 1 |
increases expression |
ISO |
Thimerosal results in increased expression of GIGYF1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr12:19,166,070...19,181,570
Ensembl chr12:19,166,088...19,175,023
|
|
G |
Gin1 |
gypsy retrotransposon integrase 1 |
increases expression |
ISO |
Thimerosal results in increased expression of GIN1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 9:98,293,596...98,315,155
Ensembl chr 9:98,293,597...98,315,848
|
|
G |
Git2 |
GIT ArfGAP 2 |
decreases expression |
ISO |
Thimerosal results in decreased expression of GIT2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr12:41,829,717...41,872,621
Ensembl chr12:41,829,730...41,871,097
|
|
G |
Gja4 |
gap junction protein, alpha 4 |
decreases expression |
ISO |
Thimerosal results in decreased expression of GJA4 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 5:139,633,324...139,635,857
Ensembl chr 5:139,633,287...139,635,925
|
|
G |
Glmp |
glycosylated lysosomal membrane protein |
decreases expression |
ISO |
Thimerosal results in decreased expression of GLMP mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 2:173,794,273...173,797,863
Ensembl chr 2:173,794,255...173,799,960
|
|
G |
Gls |
glutaminase |
increases expression |
ISO |
Thimerosal results in increased expression of GLS mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 9:49,344,616...49,416,900
Ensembl chr 9:49,344,781...49,416,900
|
|
G |
Gm2a |
ganglioside GM2 activator |
decreases expression |
ISO |
Thimerosal results in decreased expression of GM2A mRNA |
CTD |
PMID:27188386 |
|
NCBI chr10:39,219,221...39,231,756
Ensembl chr10:39,219,243...39,231,757
|
|
G |
Gmds |
GDP-mannose 4, 6-dehydratase |
decreases expression |
ISO |
Thimerosal results in decreased expression of GMDS mRNA |
CTD |
PMID:27188386 |
|
NCBI chr17:32,095,315...32,621,975
Ensembl chr17:32,095,386...32,621,961
|
|
G |
Gnal |
G protein subunit alpha L |
decreases expression |
ISO |
Thimerosal results in decreased expression of GNAL mRNA |
CTD |
PMID:27188386 |
|
NCBI chr18:60,622,311...60,762,599
Ensembl chr18:60,622,311...60,762,599
|
|
G |
Gnb1 |
G protein subunit beta 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of GNB1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 5:166,075,508...166,142,223
Ensembl chr 5:166,075,629...166,142,124
|
|
G |
Gng4 |
G protein subunit gamma 4 |
increases expression |
ISO |
Thimerosal results in increased expression of GNG4 mRNA |
CTD |
PMID:24675092 |
|
NCBI chr17:86,448,708...86,497,560
Ensembl chr17:86,449,022...86,495,254
|
|
G |
Gng7 |
G protein subunit gamma 7 |
decreases expression |
ISO |
Thimerosal results in decreased expression of GNG7 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 7:8,697,458...8,761,239
Ensembl chr 7:8,697,521...8,761,240
|
|
G |
Gnrhr |
gonadotropin releasing hormone receptor |
increases expression |
ISO |
Thimerosal results in increased expression of GNRHR mRNA |
CTD |
PMID:24675092 |
|
NCBI chr14:21,856,871...21,874,861
Ensembl chr14:21,856,871...21,874,861
|
|
G |
Gon4l |
gon-4 like |
decreases expression |
ISO |
Thimerosal results in decreased expression of GON4L mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 2:174,233,461...174,306,636
Ensembl chr 2:174,233,461...174,306,634
|
|
G |
Gpcpd1 |
glycerophosphocholine phosphodiesterase 1 |
increases expression |
ISO |
Thimerosal results in increased expression of GPCPD1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 3:119,787,681...119,832,550
Ensembl chr 3:119,787,682...119,832,517
|
|
G |
Gpi |
glucose-6-phosphate isomerase |
decreases expression |
ISO |
Thimerosal results in decreased expression of GPI mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:86,828,211...86,856,077
Ensembl chr 1:86,828,216...86,856,086
|
|
G |
Gpr135 |
G protein-coupled receptor 135 |
decreases expression |
ISO |
Thimerosal results in decreased expression of GPR135 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 6:90,627,533...90,630,661
Ensembl chr 6:90,629,178...90,630,551
|
|
G |
Gpr22 |
G protein-coupled receptor 22 |
increases expression |
ISO |
Thimerosal results in increased expression of GPR22 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 6:48,309,619...48,317,864
Ensembl chr 6:48,310,505...48,317,486
|
|
G |
Grem2 |
gremlin 2, DAN family BMP antagonist |
decreases expression |
ISO |
Thimerosal results in decreased expression of GREM2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr13:86,778,543...86,871,509
Ensembl chr13:86,778,500...86,871,615
|
|
G |
Grik2 |
glutamate ionotropic receptor kainate type subunit 2 |
increases expression |
ISO |
Thimerosal results in increased expression of GRIK2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr20:52,135,325...52,833,061
Ensembl chr20:52,133,851...52,838,375
|
|
G |
Grik5 |
glutamate ionotropic receptor kainate type subunit 5 |
affects expression |
ISO |
Thimerosal affects the expression of GRIK5 protein |
CTD |
PMID:15184908 |
|
NCBI chr 1:80,605,878...80,667,896
Ensembl chr 1:80,605,892...80,667,125
|
|
G |
Grin1 |
glutamate ionotropic receptor NMDA type subunit 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of GRIN1 protein |
CTD |
PMID:15184908 |
|
NCBI chr 3:8,103,680...8,130,603
Ensembl chr 3:8,103,680...8,130,603
|
|
G |
Grin2b |
glutamate ionotropic receptor NMDA type subunit 2B |
decreases expression |
ISO |
Thimerosal results in decreased expression of GRIN2B protein |
CTD |
PMID:15184908 |
|
NCBI chr 4:168,580,824...169,044,110
Ensembl chr 4:168,599,546...169,042,279
|
|
G |
Grk3 |
G protein-coupled receptor kinase 3 |
decreases expression |
ISO |
Thimerosal results in decreased expression of GRK3 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr12:43,624,778...43,735,375
Ensembl chr12:43,624,897...43,731,262
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
affects response to substance |
ISO |
GSTM1 affects the susceptibility to Thimerosal |
CTD |
PMID:11007341 |
|
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
|
|
G |
Gstm2 |
glutathione S-transferase mu 2 |
decreases expression |
ISO |
Thimerosal results in decreased expression of GSTM2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 2:195,624,015...195,628,774
Ensembl chr 2:195,544,426...195,628,961
|
|
G |
Gstt1 |
glutathione S-transferase theta 1 |
affects response to substance decreases expression |
ISO |
GSTT1 affects the susceptibility to Thimerosal Thimerosal results in decreased expression of GSTT1 mRNA |
CTD |
PMID:11007341 PMID:27188386 |
|
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
|
|
G |
Gtf2a1 |
general transcription factor 2A subunit 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of GTF2A1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 6:110,488,891...110,521,502
Ensembl chr 6:110,488,931...110,521,511
|
|
G |
Gtf2b |
general transcription factor IIB |
increases expression |
ISO |
Thimerosal results in increased expression of GTF2B mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 2:231,767,317...231,785,626
Ensembl chr 2:231,767,238...231,785,651
|
|
G |
Gtf2f1 |
general transcription factor IIF subunit 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of GTF2F1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 9:1,844,027...1,853,455
Ensembl chr 9:1,843,901...1,853,423
|
|
G |
Guca1a |
guanylate cyclase activator 1A |
decreases expression |
ISO |
Thimerosal results in decreased expression of GUCA1A mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 9:13,588,988...13,598,566
Ensembl chr 9:13,588,525...13,598,565
|
|
G |
Gulp1 |
GULP PTB domain containing engulfment adaptor 1 |
increases expression |
ISO |
Thimerosal results in increased expression of GULP1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 9:46,622,699...46,899,005
Ensembl chr 9:46,622,669...46,899,005
|
|
G |
Gxylt1 |
glucoside xylosyltransferase 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of GXYLT1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 7:124,400,896...124,434,682
Ensembl chr 7:124,400,896...124,434,699
|
|
G |
H1f0 |
H1.0 linker histone |
decreases expression |
ISO |
Thimerosal results in decreased expression of H1-0 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 7:110,592,834...110,594,694
Ensembl chr 7:110,592,208...110,594,694
|
|
G |
H1f10 |
H1.10 linker histone |
decreases expression |
ISO |
Thimerosal results in decreased expression of H1-10 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 4:120,440,515...120,441,578
Ensembl chr 4:120,440,870...120,441,448
|
|
G |
H1f4 |
H1.4 linker histone, cluster member |
decreases expression |
ISO |
Thimerosal results in decreased expression of H1-4 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr17:41,486,574...41,487,355
Ensembl chr17:41,486,560...41,487,403
|
|
G |
H4f3 |
H1.3 linker histone, cluster member |
decreases expression |
ISO |
Thimerosal results in decreased expression of H1-3 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr17:41,551,524...41,552,303
Ensembl chr17:41,529,667...41,552,334
|
|
G |
Hacd2 |
3-hydroxyacyl-CoA dehydratase 2 |
decreases expression |
ISO |
Thimerosal results in decreased expression of HACD2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr11:65,667,671...65,762,903
Ensembl chr11:65,670,281...65,762,889
|
|
G |
Hadha |
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha |
decreases expression |
ISO |
Thimerosal results in decreased expression of HADHA mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 6:26,187,969...26,227,605
Ensembl chr 6:26,187,956...26,227,869
|
|
G |
Hat1 |
histone acetyltransferase 1 |
increases expression |
ISO |
Thimerosal results in increased expression of HAT1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 3:56,217,344...56,265,021
Ensembl chr 3:56,217,342...56,275,517
|
|
G |
Hbegf |
heparin-binding EGF-like growth factor |
increases expression |
ISO |
Thimerosal results in increased expression of HBEGF mRNA |
CTD |
PMID:16870260 |
|
NCBI chr18:28,106,284...28,116,167
Ensembl chr18:28,105,760...28,116,441
|
|
G |
Hbs1l |
HBS1-like translational GTPase |
increases expression |
ISO |
Thimerosal results in increased expression of HBS1L mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:16,092,529...16,170,082
Ensembl chr 1:16,092,547...16,170,074
|
|
G |
Hcfc1r1 |
host cell factor C1 regulator 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of HCFC1R1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr10:12,705,139...12,706,852
Ensembl chr10:12,705,077...12,706,850
|
|
G |
Hdac4 |
histone deacetylase 4 |
multiple interactions increases expression |
ISO EXP |
MC1568 inhibits the reaction [Thimerosal results in increased expression of HDAC4 protein] |
CTD |
PMID:27660204 |
|
NCBI chr 9:92,503,467...92,750,164
Ensembl chr 9:92,507,611...92,750,164
|
|
G |
Hdx |
highly divergent homeobox |
increases expression |
ISO |
Thimerosal results in increased expression of HDX mRNA |
CTD |
PMID:27188386 |
|
NCBI chr X:76,552,539...76,697,177
Ensembl chr X:76,560,665...76,869,972
|
|
G |
Heatr1 |
HEAT repeat containing 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of HEATR1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr17:58,053,288...58,093,895
Ensembl chr17:58,051,700...58,093,948
|
|
G |
Hebp1 |
heme binding protein 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of HEBP1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 4:167,974,316...168,003,854
Ensembl chr 4:167,974,319...168,003,854
|
|
G |
Hectd1 |
HECT domain E3 ubiquitin protein ligase 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of HECTD1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 6:69,181,429...69,268,045
Ensembl chr 6:69,181,436...69,268,053
|
|
G |
Hectd2 |
HECT domain E3 ubiquitin protein ligase 2 |
increases expression |
ISO |
Thimerosal results in increased expression of HECTD2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:234,274,967...234,345,598
Ensembl chr 1:234,275,705...234,343,487
|
|
G |
Hecw1 |
HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1 |
increases expression |
ISO |
Thimerosal results in increased expression of HECW1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr17:50,671,239...51,084,536
Ensembl chr17:50,670,954...51,080,720
|
|
G |
Hells |
helicase, lymphoid specific |
increases expression |
ISO |
Thimerosal results in increased expression of HELLS mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:236,701,704...236,748,239
Ensembl chr 1:236,701,758...236,746,844
|
|
G |
Henmt1 |
HEN methyltransferase 1 |
increases expression |
ISO |
Thimerosal results in increased expression of HENMT1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 2:196,585,732...196,603,700
Ensembl chr 2:196,586,797...196,599,738
|
|
G |
Heph |
hephaestin |
decreases expression |
ISO |
Thimerosal results in decreased expression of HEPH mRNA |
CTD |
PMID:27188386 |
|
NCBI chr X:61,151,131...61,402,980
Ensembl chr X:61,296,345...61,402,980
|
|
G |
Hes1 |
hes family bHLH transcription factor 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of HES1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr11:70,705,763...70,708,176
Ensembl chr11:70,705,764...70,708,192
|
|
G |
Hes3 |
hes family bHLH transcription factor 3 |
decreases expression |
ISO |
Thimerosal results in decreased expression of HES3 mRNA |
CTD |
PMID:24675092 |
|
NCBI chr 5:162,793,611...162,799,578
Ensembl chr 5:162,794,367...162,796,261
|
|
G |
Hif3a |
hypoxia inducible factor 3 subunit alpha |
decreases expression |
ISO |
Thimerosal results in decreased expression of HIF3A mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:77,718,110...77,750,448
Ensembl chr 1:77,722,471...77,749,758
|
|
G |
Hip1 |
huntingtin interacting protein 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of HIP1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr12:21,133,364...21,267,796
Ensembl chr12:21,133,406...21,267,725
|
|
G |
Hipk2 |
homeodomain interacting protein kinase 2 |
decreases expression |
ISO |
Thimerosal results in decreased expression of HIPK2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 4:67,439,327...67,619,223
Ensembl chr 4:67,440,501...67,619,223
|
|
G |
Hk1 |
hexokinase 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of HK1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr20:30,230,488...30,332,099
Ensembl chr20:30,230,486...30,332,131
|
|
G |
Hk2 |
hexokinase 2 |
decreases expression |
ISO |
Thimerosal results in decreased expression of HK2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 4:115,234,509...115,283,530
Ensembl chr 4:115,234,509...115,283,530
|
|
G |
Hmga1 |
high mobility group AT-hook 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of HMGA1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr20:5,611,088...5,618,755
Ensembl chr20:5,611,694...5,618,752
|
|
G |
Hmgb1 |
high mobility group box 1 |
increases expression |
ISO |
Thimerosal results in increased expression of HMGB1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr12:5,972,950...5,979,658
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
|
|
G |
Hmgn5 |
high mobility group nucleosome binding domain 5 |
increases expression |
ISO |
Thimerosal results in increased expression of HMGN5 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr X:74,085,871...74,094,488
Ensembl chr X:74,085,875...74,094,441
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression |
ISO |
Thimerosal results in increased expression of HMOX1 mRNA |
CTD |
PMID:16870260 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hnrnpa0 |
heterogeneous nuclear ribonucleoprotein A0 |
decreases expression |
ISO |
Thimerosal results in decreased expression of HNRNPA0 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr17:6,507,728...6,510,385
Ensembl chr17:6,507,275...6,509,375
|
|
G |
Hnrnpul2 |
heterogeneous nuclear ribonucleoprotein U-like 2 |
decreases expression |
ISO |
Thimerosal results in decreased expression of HNRNPUL2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:205,713,431...205,725,553
Ensembl chr 1:205,711,886...205,725,553
|
|
G |
Hsd17b6 |
hydroxysteroid (17-beta) dehydrogenase 6 |
decreases expression |
ISO |
Thimerosal results in decreased expression of HSD17B6 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 7:422,466...442,008
Ensembl chr 7:422,480...442,425
|
|
G |
Hsf2 |
heat shock transcription factor 2 |
increases expression |
ISO |
Thimerosal results in increased expression of HSF2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr20:36,819,864...36,847,490
Ensembl chr20:36,819,864...36,850,174
|
|
G |
Hsp90ab1 |
heat shock protein 90 alpha family class B member 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of HSP90AB1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 9:15,432,986...15,438,358
Ensembl chr 9:15,433,691...15,438,488
|
|
G |
Hspa13 |
heat shock protein family A (Hsp70) member 13 |
increases expression |
ISO |
Thimerosal results in increased expression of HSPA13 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr11:14,375,669...14,389,853
Ensembl chr11:14,373,275...14,389,895
|
|
G |
Hspa1a |
heat shock protein family A (Hsp70) member 1A |
increases expression decreases expression |
ISO |
Thimerosal results in increased expression of HSPA1A mRNA Thimerosal results in decreased expression of HSPA1A mRNA |
CTD |
PMID:16870260 PMID:24675092 |
|
NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,856,006...3,873,227
|
|
G |
Hspa1b |
heat shock protein family A (Hsp70) member 1B |
increases expression |
ISO |
Thimerosal results in increased expression of HSPA1B mRNA |
CTD |
PMID:16870260 |
|
NCBI chr20:3,855,104...3,859,148
Ensembl chr20:3,856,006...3,873,240 Ensembl chr20:3,856,006...3,873,240
|
|
G |
Hspa1l |
heat shock protein family A (Hsp70) member 1 like |
increases expression |
ISO |
Thimerosal results in increased expression of HSPA1L mRNA |
CTD |
PMID:16870260 |
|
NCBI chr20:3,848,843...3,855,571
Ensembl chr20:3,848,843...3,855,571
|
|
G |
Hspa4l |
heat shock protein family A (Hsp70) member 4 like |
increases expression |
ISO |
Thimerosal results in increased expression of HSPA4L mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 2:123,740,384...123,793,088
Ensembl chr 2:123,740,384...123,793,084
|
|
G |
Hspa6l-ps1 |
heat shock protein family A (Hsp70) member 6 like, pseudogene 1 |
increases expression |
ISO |
Thimerosal results in increased expression of HSPA6 mRNA |
CTD |
PMID:16870260 |
|
NCBI chr13:83,273,176...83,274,317
|
|
G |
Hspb1 |
heat shock protein family B (small) member 1 |
increases expression |
ISO |
Thimerosal results in increased expression of HSPB1 mRNA |
CTD |
PMID:16870260 |
|
NCBI chr12:20,794,014...20,795,675
Ensembl chr12:20,794,028...20,795,743
|
|
G |
Htatsf1 |
HIV-1 Tat specific factor 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of HTATSF1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr X:134,935,426...134,949,607
Ensembl chr X:134,935,426...134,949,607
|
|
G |
Htr2c |
5-hydroxytryptamine receptor 2C |
increases expression |
ISO |
Thimerosal results in increased expression of HTR2C mRNA |
CTD |
PMID:27188386 |
|
NCBI chr X:110,640,777...110,870,288
Ensembl chr X:110,641,153...110,870,287
|
|
G |
Hyls1 |
HYLS1, centriolar and ciliogenesis associated |
increases expression |
ISO |
Thimerosal results in increased expression of HYLS1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 8:33,912,692...33,921,760
Ensembl chr 8:33,912,692...33,921,760
|
|
G |
Ier5l |
immediate early response 5-like |
decreases expression |
ISO |
Thimerosal results in decreased expression of IER5L mRNA |
CTD |
PMID:24675092 PMID:27188386 |
|
NCBI chr 3:13,744,056...13,745,647
Ensembl chr 3:13,744,078...13,745,647
|
|
G |
Ifng |
interferon gamma |
affects response to substance multiple interactions |
ISO |
IFNG affects the susceptibility to Thimerosal Glutathione inhibits the reaction [Thimerosal inhibits the reaction [Lipopolysaccharides results in increased secretion of IFNG protein]]; Thimerosal inhibits the reaction [Lipopolysaccharides results in increased secretion of IFNG protein] |
CTD |
PMID:15808517 PMID:17079650 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Ift80 |
intraflagellar transport 80 |
increases expression |
ISO |
Thimerosal results in increased expression of IFT80 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 2:153,144,707...153,240,024
Ensembl chr 2:153,145,795...153,240,024
|
|
G |
Igdcc3 |
immunoglobulin superfamily, DCC subclass, member 3 |
decreases expression |
ISO |
Thimerosal results in decreased expression of IGDCC3 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 8:65,661,165...65,707,961
Ensembl chr 8:65,661,196...65,707,959
|
|
G |
Igf1 |
insulin-like growth factor 1 |
multiple interactions |
ISO |
Thimerosal affects the reaction [IGF1 protein results in increased activity of MTR protein] IGF1 protein inhibits the reaction [Thimerosal results in decreased expression of BIRC5 protein]; IGF1 protein inhibits the reaction [Thimerosal results in increased cleavage of CASP3 protein]; IGF1 protein inhibits the reaction [Thimerosal results in increased cleavage of CASP9 protein] |
CTD |
PMID:14745455 PMID:23145070 |
|
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Igf2bp3 |
insulin-like growth factor 2 mRNA binding protein 3 |
decreases expression |
ISO |
Thimerosal results in decreased expression of IGF2BP3 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 4:78,060,494...78,195,007
Ensembl chr 4:78,060,494...78,194,865
|
|
G |
Igfbp2 |
insulin-like growth factor binding protein 2 |
decreases expression |
ISO |
Thimerosal results in decreased expression of IGFBP2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 9:74,415,574...74,442,945
Ensembl chr 9:74,415,546...74,442,937
|
|
G |
Igfbp5 |
insulin-like growth factor binding protein 5 |
decreases expression |
ISO |
Thimerosal results in decreased expression of IGFBP5 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 9:74,452,371...74,464,953
Ensembl chr 9:74,448,382...74,465,156
|
|
G |
Iglon5 |
IgLON family member 5 |
decreases expression |
ISO |
Thimerosal results in decreased expression of IGLON5 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:93,880,906...93,898,929
Ensembl chr 1:93,881,991...93,898,754
|
|
G |
Ikzf1 |
IKAROS family zinc finger 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of IKZF1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr14:86,255,065...86,340,839
Ensembl chr14:86,255,065...86,342,416
|
|
G |
Il13 |
interleukin 13 |
multiple interactions |
ISO |
[Thimerosal co-treated with Lipopolysaccharides] results in increased secretion of IL13 protein; Glutathione inhibits the reaction [[Thimerosal co-treated with Lipopolysaccharides] results in increased secretion of IL13 protein] |
CTD |
PMID:17079650 |
|
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
|
|
G |
Il13ra1 |
interleukin 13 receptor subunit alpha 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of IL13RA1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr X:115,348,822...115,408,682
Ensembl chr X:115,348,860...115,408,681 Ensembl chr11:115,348,860...115,408,681
|
|
G |
Il17ra |
interleukin 17 receptor A |
decreases expression |
ISO |
Thimerosal results in decreased expression of IL17RA mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 4:153,667,534...153,690,174
Ensembl chr 4:153,667,534...153,690,174
|
|
G |
Il27ra |
interleukin 27 receptor subunit alpha |
decreases expression |
ISO |
Thimerosal results in decreased expression of IL27RA mRNA |
CTD |
PMID:27188386 |
|
NCBI chr19:24,109,963...24,121,977
Ensembl chr19:24,109,972...24,121,938
|
|
G |
Il5 |
interleukin 5 |
multiple interactions |
ISO |
[Thimerosal co-treated with Lipopolysaccharides] results in increased secretion of IL5 protein |
CTD |
PMID:17079650 |
|
NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
|
|
G |
Il6 |
interleukin 6 |
affects response to substance multiple interactions |
ISO |
IL6 affects the susceptibility to Thimerosal Glutathione inhibits the reaction [Thimerosal inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]]; Thimerosal inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein] |
CTD |
PMID:15808517 PMID:17079650 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Ilf3 |
interleukin enhancer binding factor 3 |
decreases expression |
ISO |
Thimerosal results in decreased expression of ILF3 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 8:19,922,409...19,960,495
Ensembl chr 8:19,922,460...19,960,350
|
|
G |
Ilrun |
inflammation and lipid regulator with UBA-like and NBR1-like domains |
decreases expression |
ISO |
Thimerosal results in decreased expression of ILRUN mRNA |
CTD |
PMID:27188386 |
|
NCBI chr20:5,809,931...5,876,197
Ensembl chr20:5,809,936...5,876,012
|
|
G |
Immp1l |
inner mitochondrial membrane peptidase subunit 1 |
increases expression |
ISO |
Thimerosal results in increased expression of IMMP1L mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 3:92,385,329...92,449,559
Ensembl chr 3:92,385,379...92,452,313
|
|
G |
Inafm1 |
InaF-motif containing 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of INAFM1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:76,976,808...76,978,292
|
|
G |
Ing3 |
inhibitor of growth family, member 3 |
increases expression |
ISO |
Thimerosal results in increased expression of ING3 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 4:50,477,954...50,505,168
Ensembl chr 4:50,477,962...50,503,715
|
|
G |
Ino80d |
INO80 complex subunit D |
increases expression |
ISO |
Thimerosal results in increased expression of INO80D mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 9:64,447,075...64,514,013
Ensembl chr 9:64,457,165...64,515,242
|
|
G |
Insig1 |
insulin induced gene 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of INSIG1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 4:7,315,494...7,323,972
Ensembl chr 4:7,315,495...7,323,952
|
|
G |
Ints10 |
integrator complex subunit 10 |
increases expression |
ISO |
Thimerosal results in increased expression of INTS10 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr16:20,915,223...20,947,146
Ensembl chr16:20,916,082...20,967,610
|
|
G |
Ints14 |
integrator complex subunit 14 |
increases expression |
ISO |
Thimerosal results in increased expression of INTS14 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 8:65,475,788...65,500,807
Ensembl chr 8:65,475,910...65,500,804
|
|
G |
Ints6 |
integrator complex subunit 6 |
increases expression |
ISO |
Thimerosal results in increased expression of INTS6 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr15:36,908,966...37,048,043
Ensembl chr15:36,933,724...37,021,527
|
|
G |
Iqgap1 |
IQ motif containing GTPase activating protein 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of IQGAP1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:134,679,581...134,769,776
Ensembl chr 1:134,679,586...134,769,755
|
|
G |
Irag1 |
inositol 1,4,5-triphosphate receptor associated 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of IRAG1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:164,981,716...165,094,232
Ensembl chr 1:164,981,716...165,094,176
|
|
G |
Irf2bp2 |
interferon regulatory factor 2 binding protein 2 |
decreases expression |
ISO |
Thimerosal results in decreased expression of IRF2BP2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr19:54,559,417...54,565,096
Ensembl chr19:54,560,128...54,566,642
|
|
G |
Isyna1 |
inositol-3-phosphate synthase 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of ISYNA1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr16:18,839,143...18,841,979
Ensembl chr16:18,839,145...18,841,979
|
|
G |
Itpr3 |
inositol 1,4,5-trisphosphate receptor, type 3 |
decreases expression |
ISO |
Thimerosal results in decreased expression of ITPR3 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr20:5,136,968...5,202,339
Ensembl chr20:5,136,441...5,202,337
|
|
G |
Itprid2 |
ITPR interacting domain containing 2 |
decreases expression |
ISO |
Thimerosal results in decreased expression of ITPRID2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 3:64,536,707...64,573,978
Ensembl chr 3:64,536,707...64,573,978
|
|
G |
Itpripl1 |
ITPRIP like 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of ITPRIPL1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 3:114,403,123...114,407,917
Ensembl chr 3:114,402,270...114,414,497
|
|
G |
Itpripl2 |
ITPRIP like 2 |
decreases expression |
ISO |
Thimerosal results in decreased expression of ITPRIPL2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:172,801,152...172,803,047
Ensembl chr 1:172,796,849...172,802,950
|
|
G |
Itsn2 |
intersectin 2 |
decreases expression |
ISO |
Thimerosal results in decreased expression of ITSN2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 6:27,616,645...27,727,373
Ensembl chr 6:27,600,406...27,727,124
|
|
G |
Iws1 |
interacts with SUPT6H, CTD assembly factor 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of IWS1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr18:23,695,496...23,737,363
Ensembl chr18:23,695,425...23,736,172
|
|
G |
Jmjd1c |
jumonji domain containing 1C |
decreases expression |
ISO |
Thimerosal results in decreased expression of JMJD1C mRNA |
CTD |
PMID:27188386 |
|
NCBI chr20:21,332,147...21,494,220
Ensembl chr20:21,332,147...21,463,122
|
|
G |
Jph3 |
junctophilin 3 |
decreases expression |
ISO |
Thimerosal results in decreased expression of JPH3 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr19:49,793,967...49,855,338
Ensembl chr19:49,793,092...49,855,338
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
increases expression |
ISO |
Thimerosal results in increased expression of JUN mRNA |
CTD |
PMID:16870260 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Jund |
JunD proto-oncogene, AP-1 transcription factor subunit |
decreases expression |
ISO |
Thimerosal results in decreased expression of JUND mRNA |
CTD |
PMID:27188386 |
|
NCBI chr16:18,734,121...18,735,799
Ensembl chr16:18,734,122...18,735,799
|
|
G |
Kansl1l |
KAT8 regulatory NSL complex subunit 1-like |
increases expression |
ISO |
Thimerosal results in increased expression of KANSL1L mRNA |
CTD |
PMID:16870260 |
|
NCBI chr 9:68,211,151...68,316,992
Ensembl chr 9:68,211,189...68,300,222
|
|
G |
Kat2b |
lysine acetyltransferase 2B |
increases expression |
ISO |
Thimerosal results in increased expression of KAT2B mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 9:6,562,525...6,667,064
Ensembl chr 9:6,562,288...6,667,064
|
|
G |
Kat6a |
lysine acetyltransferase 6A |
decreases expression |
ISO |
Thimerosal results in decreased expression of KAT6A mRNA |
CTD |
PMID:27188386 |
|
NCBI chr16:69,084,914...69,165,923
Ensembl chr16:69,084,914...69,163,606
|
|
G |
Kat8 |
lysine acetyltransferase 8 |
decreases expression |
ISO |
Thimerosal results in decreased expression of KAT8 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:182,524,355...182,536,638
Ensembl chr 1:182,515,327...182,536,633
|
|
G |
Kbtbd2 |
kelch repeat and BTB domain containing 2 |
decreases expression |
ISO |
Thimerosal results in decreased expression of KBTBD2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 4:86,027,947...86,050,266
Ensembl chr 4:86,027,947...86,050,211
|
|
G |
Kbtbd8 |
kelch repeat and BTB domain containing 8 |
increases expression |
ISO |
Thimerosal results in increased expression of KBTBD8 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 4:127,675,967...127,688,785
Ensembl chr 4:127,676,141...127,687,697
|
|
G |
Kcnb2 |
potassium voltage-gated channel subfamily B member 2 |
increases expression |
ISO |
Thimerosal results in increased expression of KCNB2 mRNA |
CTD |
PMID:24675092 |
|
NCBI chr 5:3,567,012...4,028,564
Ensembl chr 5:3,569,685...4,028,599
|
|
G |
Kcnip3 |
potassium voltage-gated channel interacting protein 3 |
multiple interactions |
ISO |
[SOD1 protein mutant form results in increased susceptibility to Thimerosal] which results in increased acetylation of and results in increased ubiquitination of KCNIP3 protein; [SOD1 protein results in increased susceptibility to Thimerosal] which results in decreased expression of KCNIP3 protein; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [[SOD1 protein results in increased susceptibility to Thimerosal] which results in decreased expression of KCNIP3 protein]; Resveratrol inhibits the reaction [[SOD1 protein mutant form results in increased susceptibility to Thimerosal] which results in increased acetylation of and results in increased ubiquitination of KCNIP3 protein]; Resveratrol inhibits the reaction [[SOD1 protein results in increased susceptibility to Thimerosal] which results in decreased expression of KCNIP3 protein]; SIRT1 protein affects the reaction [Resveratrol inhibits the reaction [[SOD1 protein results in increased susceptibility to Thimerosal] which results in decreased expression of KCNIP3 protein]] |
CTD |
PMID:30503815 |
|
NCBI chr 3:114,677,027...114,742,923
Ensembl chr 3:114,677,030...114,743,556
|
|
G |
Kcnrg |
potassium channel regulator |
increases expression |
ISO |
Thimerosal results in increased expression of KCNRG mRNA |
CTD |
PMID:27188386 |
|
NCBI chr15:35,774,456...35,779,409
Ensembl chr15:35,774,326...35,779,415
|
|
G |
Kdelr1 |
KDEL endoplasmic reticulum protein retention receptor 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of KDELR1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:96,347,258...96,358,145
Ensembl chr 1:96,347,150...96,358,157
|
|
G |
Kdm4b |
lysine demethylase 4B |
decreases expression |
ISO |
Thimerosal results in decreased expression of KDM4B mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 9:1,158,737...1,237,233
Ensembl chr 9:1,158,752...1,236,543
|
|
G |
Kdm6a |
lysine demethylase 6A |
decreases expression |
ISO |
Thimerosal results in decreased expression of KDM6A mRNA |
CTD |
PMID:27188386 |
|
NCBI chr X:4,337,466...4,477,100
Ensembl chr X:4,337,750...4,477,062
|
|
G |
Khk |
ketohexokinase |
decreases expression |
ISO |
Thimerosal results in decreased expression of KHK mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 6:25,445,298...25,455,834
Ensembl chr 6:25,445,300...25,455,717
|
|
G |
Kif1a |
kinesin family member 1A |
decreases expression |
ISO |
Thimerosal results in decreased expression of KIF1A mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 9:93,563,033...93,647,412
Ensembl chr 9:93,563,045...93,647,480
|
|
G |
Kif21b |
kinesin family member 21B |
decreases expression |
ISO |
Thimerosal results in decreased expression of KIF21B mRNA |
CTD |
PMID:24675092 |
|
NCBI chr13:47,576,129...47,626,112
Ensembl chr13:47,576,160...47,626,127
|
|
G |
Kif22 |
kinesin family member 22 |
decreases expression |
ISO |
Thimerosal results in decreased expression of KIF22 mRNA |
CTD |
PMID:24675092 |
|
NCBI chr 1:181,635,347...181,650,351
Ensembl chr 1:181,635,183...181,650,401
|
|
G |
Kiss1r |
KISS1 receptor |
decreases expression |
ISO |
Thimerosal results in decreased expression of KISS1R mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 7:9,785,135...9,790,283
Ensembl chr 7:9,785,135...9,788,793
|
|
G |
Klf12 |
KLF transcription factor 12 |
increases expression |
ISO |
Thimerosal results in increased expression of KLF12 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr15:76,628,778...77,062,000
Ensembl chr15:76,637,654...77,062,056
|
|
G |
Klf13 |
KLF transcription factor 13 |
decreases expression |
ISO |
Thimerosal results in decreased expression of KLF13 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:117,505,857...117,536,626
Ensembl chr 1:117,503,602...117,551,227
|
|
G |
Klf15 |
KLF transcription factor 15 |
increases expression |
ISO |
Thimerosal results in increased expression of KLF15 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 4:122,965,718...122,978,403
Ensembl chr 4:122,965,807...122,978,374
|
|
G |
Klf4 |
KLF transcription factor 4 |
increases expression |
ISO |
Thimerosal results in increased expression of KLF4 mRNA |
CTD |
PMID:16870260 |
|
NCBI chr 5:70,278,843...70,283,751
Ensembl chr 5:70,278,972...70,283,602
|
|
G |
Klhdc10 |
kelch domain containing 10 |
decreases expression |
ISO |
Thimerosal results in decreased expression of KLHDC10 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 4:59,021,300...59,079,118
Ensembl chr 4:59,021,310...59,074,941
|
|
G |
Klhl24 |
kelch-like family member 24 |
decreases expression |
ISO |
Thimerosal results in decreased expression of KLHL24 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr11:80,843,621...80,877,649
Ensembl chr11:80,846,755...80,877,636
|
|
G |
Klhl3 |
kelch-like family member 3 |
decreases expression |
ISO |
Thimerosal results in decreased expression of KLHL3 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr17:6,523,089...6,645,971
Ensembl chr17:6,521,912...6,642,154
|
|
G |
Klhl41 |
kelch-like family member 41 |
increases expression |
ISO |
Thimerosal results in increased expression of KLHL41 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 3:54,434,291...54,447,415
Ensembl chr 3:54,434,234...54,449,222
|
|
G |
Kmt2a |
lysine methyltransferase 2A |
decreases expression |
ISO |
Thimerosal results in decreased expression of KMT2A mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 8:45,116,763...45,193,320
Ensembl chr 8:45,118,814...45,193,181
|
|
G |
Knl1 |
kinetochore scaffold 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of KNL1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 3:106,029,627...106,091,915
Ensembl chr 3:106,029,661...106,091,915
|
|
G |
Kras |
KRAS proto-oncogene, GTPase |
decreases expression |
ISO |
Thimerosal results in decreased expression of KRAS mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 4:178,185,418...178,218,484
|
|
G |
Krcc1 |
lysine-rich coiled-coil 1 |
increases expression |
ISO |
Thimerosal results in increased expression of KRCC1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 4:103,261,642...103,274,672
Ensembl chr 4:103,261,536...103,277,156
|
|
G |
Krr1 |
KRR1, small subunit processome component homolog |
increases expression |
ISO |
Thimerosal results in increased expression of KRR1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 7:47,475,557...47,486,996
Ensembl chr 7:47,475,557...47,486,985
|
|
G |
Larp1b |
La ribonucleoprotein 1B |
increases expression |
ISO |
Thimerosal results in increased expression of LARP1B mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 2:123,936,057...123,969,254
Ensembl chr 2:123,935,983...123,968,896
|
|
G |
Larp4 |
La ribonucleoprotein 4 |
decreases expression |
ISO |
Thimerosal results in decreased expression of LARP4 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 7:131,104,470...131,152,692
Ensembl chr 7:131,101,564...131,150,811
|
|
G |
Larp7 |
La ribonucleoprotein 7, transcriptional regulator |
increases expression |
ISO |
Thimerosal results in increased expression of LARP7 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 2:215,997,641...216,012,833
Ensembl chr 2:215,997,649...216,012,865
|
|
G |
Lars1 |
leucyl-tRNA synthetase 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of LARS1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr18:34,201,555...34,256,003
Ensembl chr18:34,201,549...34,255,931
|
|
G |
Lcorl |
ligand dependent nuclear receptor corepressor-like |
increases expression |
ISO |
Thimerosal results in increased expression of LCORL mRNA |
CTD |
PMID:27188386 |
|
NCBI chr14:65,271,339...65,407,732
Ensembl chr14:65,271,135...65,404,174
|
|
G |
Ldha |
lactate dehydrogenase A |
decreases expression |
ISO |
Thimerosal results in decreased expression of LDHA mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:97,371,823...97,381,247
Ensembl chr 1:97,366,021...97,433,472
|
|
G |
Lgals3bp |
galectin 3 binding protein |
decreases expression |
ISO |
Thimerosal results in decreased expression of LGALS3BP mRNA |
CTD |
PMID:27188386 |
|
NCBI chr10:103,619,912...103,629,251
Ensembl chr10:103,619,908...103,629,256
|
|
G |
Lgalsl |
galectin-like |
decreases expression |
ISO |
Thimerosal results in decreased expression of LGALSL mRNA |
CTD |
PMID:27188386 |
|
NCBI chr14:94,996,991...95,004,499
Ensembl chr14:94,996,990...95,004,980
|
|
G |
Lgr5 |
leucine rich repeat containing G protein coupled receptor 5 |
increases expression |
ISO |
Thimerosal results in increased expression of LGR5 mRNA |
CTD |
PMID:24675092 |
|
NCBI chr 7:51,087,059...51,221,882
Ensembl chr 7:51,088,239...51,222,446
|
|
G |
Lgr6 |
leucine-rich repeat-containing G protein-coupled receptor 6 |
increases expression |
ISO |
Thimerosal results in increased expression of LGR6 mRNA |
CTD |
PMID:24675092 |
|
NCBI chr13:46,424,382...46,544,074
Ensembl chr13:46,424,383...46,543,945
|
|
G |
Lhb |
luteinizing hormone subunit beta |
increases expression |
ISO |
Thimerosal results in increased expression of LHB mRNA; Thimerosal results in increased expression of LHB protein |
CTD |
PMID:24675092 |
|
NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
|
|
G |
Lhx9 |
LIM homeobox 9 |
decreases expression |
ISO |
Thimerosal results in decreased expression of LHX9 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr13:50,389,052...50,409,947
Ensembl chr13:50,389,738...50,410,806
|
|
G |
Lima1 |
LIM domain and actin binding 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of LIMA1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 7:130,901,717...131,001,512
Ensembl chr 7:130,901,717...131,001,473
|
|
G |
Lims1 |
LIM zinc finger domain containing 1 |
increases expression |
ISO |
Thimerosal results in increased expression of LIMS1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr20:26,309,833...26,418,511
Ensembl chr20:26,309,895...26,418,500
|
|
G |
Lin7c |
lin-7 homolog C, crumbs cell polarity complex component |
increases expression |
ISO |
Thimerosal results in increased expression of LIN7C mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 3:96,406,800...96,417,779
Ensembl chr 3:96,406,813...96,417,728
|
|
G |
Lin9 |
lin-9 DREAM MuvB core complex component |
increases expression |
ISO |
Thimerosal results in increased expression of LIN9 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr13:92,374,612...92,419,664
Ensembl chr13:92,374,593...92,419,654
|
|
G |
Litaf |
lipopolysaccharide-induced TNF factor |
decreases expression |
ISO |
Thimerosal results in decreased expression of LITAF mRNA |
CTD |
PMID:27188386 |
|
NCBI chr10:4,656,308...4,692,981
Ensembl chr10:4,625,552...4,692,763
|
|
G |
Lix1l |
limb and CNS expressed 1 like |
decreases expression |
ISO |
Thimerosal results in decreased expression of LIX1L mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 2:184,136,018...184,161,918
Ensembl chr 2:184,136,038...184,161,916
|
|
G |
Lmbrd2 |
LMBR1 domain containing 2 |
increases expression |
ISO |
Thimerosal results in increased expression of LMBRD2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 2:58,189,558...58,251,565
Ensembl chr 2:58,189,558...58,247,076
|
|
G |
Lmf1 |
lipase maturation factor 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of LMF1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr10:14,597,726...14,684,071
Ensembl chr10:14,597,594...14,684,119
|
|
G |
Lnpep |
leucyl and cystinyl aminopeptidase |
multiple interactions |
ISO |
[NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LNPEP mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:58,258,642...58,355,532
Ensembl chr 1:58,258,642...58,354,544
|
|
G |
Lpcat1 |
lysophosphatidylcholine acyltransferase 1 |
increases expression |
ISO |
Thimerosal results in increased expression of LPCAT1 mRNA |
CTD |
PMID:24675092 |
|
NCBI chr 1:29,766,070...29,816,401
Ensembl chr 1:29,766,071...29,816,401
|
|
G |
Lpgat1 |
lysophosphatidylglycerol acyltransferase 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of LPGAT1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr13:103,294,622...103,365,372
Ensembl chr13:103,294,528...103,362,333
|
|
G |
Lrp6 |
LDL receptor related protein 6 |
decreases expression |
ISO |
Thimerosal results in decreased expression of LRP6 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 4:167,269,856...167,400,364
Ensembl chr 4:167,270,353...167,400,497
|
|
G |
Lrpprc |
leucine-rich pentatricopeptide repeat containing |
increases expression |
ISO |
Thimerosal results in increased expression of LRPPRC mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 6:9,859,816...9,942,294
Ensembl chr 6:9,859,867...9,942,293
|
|
G |
Lrrc26 |
leucine rich repeat containing 26 |
decreases expression |
ISO |
Thimerosal results in decreased expression of LRRC26 mRNA |
CTD |
PMID:24675092 |
|
NCBI chr 3:8,102,361...8,103,687
Ensembl chr 3:8,102,361...8,103,687
|
|
G |
Lrrc7 |
leucine rich repeat containing 7 |
increases expression |
ISO |
Thimerosal results in increased expression of LRRC7 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 2:247,146,616...247,634,945
Ensembl chr 2:247,147,752...247,634,547
|
|
G |
Lrrc75b |
leucine rich repeat containing 75B |
decreases expression |
ISO |
Thimerosal results in decreased expression of LRRC75B mRNA |
CTD |
PMID:27188386 |
|
NCBI chr20:13,100,302...13,106,503
Ensembl chr20:13,100,302...13,106,503
|
|
G |
Lsm12 |
LSM12 homolog |
decreases expression |
ISO |
Thimerosal results in decreased expression of LSM12 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr10:87,118,334...87,140,395
Ensembl chr10:87,118,416...87,140,396
|
|
G |
Lsm14b |
LSM family member 14B |
decreases expression |
ISO |
Thimerosal results in decreased expression of LSM14B mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 3:167,125,633...167,136,417
Ensembl chr 3:167,125,628...167,136,432
|
|
G |
Lsm5 |
LSM5 homolog, U6 small nuclear RNA and mRNA degradation associated |
increases expression |
ISO |
Thimerosal results in increased expression of LSM5 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 4:85,951,073...85,954,289
Ensembl chr 6:104,652,477...104,654,165 Ensembl chr 4:104,652,477...104,654,165
|
|
G |
Lss |
lanosterol synthase |
decreases expression |
ISO |
Thimerosal results in decreased expression of LSS mRNA |
CTD |
PMID:27188386 |
|
NCBI chr20:12,091,138...12,118,858
Ensembl chr20:12,092,774...12,118,762
|
|
G |
Lta4h |
leukotriene A4 hydrolase |
decreases expression |
ISO |
Thimerosal results in decreased expression of LTA4H mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 7:27,969,796...28,001,600
Ensembl chr 7:27,969,789...28,001,600
|
|
G |
Ltbp2 |
latent transforming growth factor beta binding protein 2 |
decreases expression |
ISO |
Thimerosal results in decreased expression of LTBP2 mRNA |
CTD |
PMID:24675092 |
|
NCBI chr 6:104,429,947...104,530,498
Ensembl chr 6:104,429,947...104,526,208
|
|
G |
Ltn1 |
listerin E3 ubiquitin protein ligase 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of LTN1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr11:26,603,903...26,660,871
Ensembl chr11:26,603,903...26,660,886
|
|
G |
Luzp1 |
leucine zipper protein 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of LUZP1 mRNA |
CTD |
PMID:24675092 |
|
NCBI chr 5:148,706,094...148,781,616
Ensembl chr 5:148,706,138...148,781,609
|
|
G |
Lysmd4 |
LysM domain containing 4 |
decreases expression |
ISO |
Thimerosal results in decreased expression of LYSMD4 mRNA |
CTD |
PMID:24675092 |
|
NCBI chr 1:120,839,180...120,845,148
Ensembl chr 1:120,839,282...120,845,135
|
|
G |
Mafb |
MAF bZIP transcription factor B |
increases expression |
ISO |
Thimerosal results in increased expression of MAFB mRNA |
CTD |
PMID:16870260 |
|
NCBI chr 3:148,998,111...149,000,031
Ensembl chr 3:148,998,122...149,000,031
|
|
G |
Maff |
MAF bZIP transcription factor F |
decreases expression |
ISO |
Thimerosal results in decreased expression of MAFF mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 7:110,912,367...110,923,711
Ensembl chr 7:110,912,499...110,923,851
|
|
G |
Magel2 |
MAGE family member L2 |
decreases expression |
ISO |
Thimerosal results in decreased expression of MAGEL2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:115,880,142...115,884,684
Ensembl chr 1:115,880,474...115,884,250
|
|
G |
Magi2 |
membrane associated guanylate kinase, WW and PDZ domain containing 2 |
decreases expression |
ISO |
Thimerosal results in decreased expression of MAGI2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 4:14,386,389...15,870,036
Ensembl chr 4:14,386,399...15,870,240
|
|
G |
Mansc1 |
MANSC domain containing 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of MANSC1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 4:167,438,817...167,459,047
Ensembl chr 4:167,439,071...167,479,606
|
|
G |
Maoa |
monoamine oxidase A |
multiple interactions |
ISO |
[NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAOA mRNA |
CTD |
PMID:27188386 |
|
NCBI chr X:6,032,172...6,098,308
Ensembl chr X:6,030,795...6,099,593
|
|
G |
Map2k2 |
mitogen activated protein kinase kinase 2 |
decreases expression |
ISO |
Thimerosal results in decreased expression of MAP2K2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 7:8,590,729...8,610,279
Ensembl chr 7:8,580,905...8,610,243
|
|
G |
Map3k11 |
mitogen-activated protein kinase kinase kinase 11 |
decreases expression |
ISO |
Thimerosal results in decreased expression of MAP3K11 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:202,975,353...202,988,655
Ensembl chr 1:202,975,353...202,988,652
|
|
G |
Map3k3 |
mitogen activated protein kinase kinase kinase 3 |
decreases expression |
ISO |
Thimerosal results in decreased expression of MAP3K3 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr10:91,020,174...91,088,852
Ensembl chr10:91,020,174...91,088,848
|
|
G |
Map3k6 |
mitogen-activated protein kinase kinase kinase 6 |
decreases expression |
ISO |
Thimerosal results in decreased expression of MAP3K6 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 5:145,440,126...145,452,213
Ensembl chr 5:145,440,346...145,452,212
|
|
G |
Map4 |
microtubule-associated protein 4 |
decreases expression |
ISO |
Thimerosal results in decreased expression of MAP4 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 8:109,925,233...110,064,370
Ensembl chr 8:109,925,575...110,064,362
|
|
G |
Map4k1 |
mitogen activated protein kinase kinase kinase kinase 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of MAP4K1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:84,270,951...84,292,496
Ensembl chr 1:84,271,069...84,292,493
|
|
G |
Map4k5 |
mitogen-activated protein kinase kinase kinase kinase 5 |
decreases expression |
ISO |
Thimerosal results in decreased expression of MAP4K5 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 6:88,284,087...88,377,118
Ensembl chr 6:88,284,094...88,376,799
|
|
G |
Map9 |
microtubule-associated protein 9 |
increases expression |
ISO |
Thimerosal results in increased expression of MAP9 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 2:167,708,661...167,743,927
Ensembl chr 2:167,708,765...167,740,736
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions decreases phosphorylation |
ISO |
Acetylcysteine inhibits the reaction [Thimerosal results in decreased phosphorylation of MAPK1 protein]; SB 203580 inhibits the reaction [Thimerosal results in decreased phosphorylation of MAPK1 protein] |
CTD |
PMID:18495191 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk14 |
mitogen activated protein kinase 14 |
increases phosphorylation decreases expression |
ISO |
Thimerosal results in increased phosphorylation of MAPK14 protein Thimerosal results in decreased expression of MAPK14 mRNA |
CTD |
PMID:15737199 PMID:27188386 |
|
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
decreases phosphorylation multiple interactions increases phosphorylation |
ISO |
Thimerosal results in decreased phosphorylation of MAPK3 protein Acetylcysteine inhibits the reaction [Thimerosal results in decreased phosphorylation of MAPK3 protein]; SB 203580 inhibits the reaction [Thimerosal results in decreased phosphorylation of MAPK3 protein] Thimerosal results in increased phosphorylation of MAPK3 protein |
CTD |
PMID:17698513 PMID:18495191 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
increases phosphorylation increases expression |
ISO |
Thimerosal results in increased phosphorylation of MAPK8 protein Thimerosal results in increased expression of MAPK8 mRNA |
CTD |
PMID:18495191 PMID:27188386 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mapk9 |
mitogen-activated protein kinase 9 |
increases phosphorylation |
ISO |
Thimerosal results in increased phosphorylation of MAPK9 protein |
CTD |
PMID:17698513 |
|
NCBI chr10:34,169,661...34,211,138
Ensembl chr10:34,169,675...34,210,178
|
|
G |
Mapkapk2 |
MAPK activated protein kinase 2 |
decreases expression |
ISO |
Thimerosal results in decreased expression of MAPKAPK2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr13:42,513,762...42,560,061
Ensembl chr13:42,513,762...42,560,457
|
|
G |
Marchf1 |
membrane associated ring-CH-type finger 1 |
increases expression |
ISO |
Thimerosal results in increased expression of MARCHF1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr16:23,255,551...24,114,290
Ensembl chr16:23,258,799...24,114,277
|
|
G |
Mark4 |
microtubule affinity regulating kinase 4 |
decreases expression |
ISO |
Thimerosal results in decreased expression of MARK4 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:79,075,353...79,108,882
Ensembl chr 1:79,068,904...79,108,556
|
|
G |
Mbd2 |
methyl-CpG binding domain protein 2 |
decreases expression |
ISO |
Thimerosal results in decreased expression of MBD2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr18:64,174,002...64,240,795
Ensembl chr18:64,174,002...64,240,794
|
|
G |
Mbnl2 |
muscleblind-like splicing regulator 2 |
decreases expression |
ISO |
Thimerosal results in decreased expression of MBNL2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr15:97,385,278...97,542,924
Ensembl chr15:97,385,244...97,542,937
|
|
G |
Mboat7 |
membrane bound O-acyltransferase domain containing 7 |
decreases expression |
ISO |
Thimerosal results in decreased expression of MBOAT7 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:65,525,206...65,539,538
Ensembl chr 1:65,525,213...65,539,538
|
|
G |
Mcph1 |
microcephalin 1 |
increases expression |
ISO |
Thimerosal results in increased expression of MCPH1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr16:71,021,855...71,224,067
Ensembl chr16:71,024,588...71,224,122
|
|
G |
Mdh2 |
malate dehydrogenase 2 |
decreases expression |
ISO |
Thimerosal results in decreased expression of MDH2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr12:20,894,269...20,907,225
Ensembl chr12:20,894,262...20,907,271
|
|
G |
Meak7 |
MTOR associated protein, eak-7 homolog |
decreases expression |
ISO |
Thimerosal results in decreased expression of MEAK7 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr19:47,813,899...47,836,830
Ensembl chr19:47,811,416...47,841,278
|
|
G |
Mecom |
MDS1 and EVI1 complex locus |
increases expression |
ISO |
Thimerosal results in increased expression of MECOM mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 2:112,909,353...113,464,583
Ensembl chr 2:112,909,321...113,464,590
|
|
G |
Med13 |
mediator complex subunit 13 |
decreases expression |
ISO |
Thimerosal results in decreased expression of MED13 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr10:71,086,978...71,176,535
Ensembl chr10:71,090,516...71,177,242
|
|
G |
Med13l |
mediator complex subunit 13L |
increases expression |
ISO |
Thimerosal results in increased expression of MED13L mRNA |
CTD |
PMID:27188386 |
|
NCBI chr12:37,807,596...38,004,886
Ensembl chr12:37,808,285...38,004,473
|
|
G |
Med16 |
mediator complex subunit 16 |
decreases expression |
ISO |
Thimerosal results in decreased expression of MED16 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 7:9,798,641...9,811,172
Ensembl chr 7:9,798,668...9,811,172
|
|
G |
Med17 |
mediator complex subunit 17 |
increases expression |
ISO |
Thimerosal results in increased expression of MED17 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 8:12,101,594...12,120,592
Ensembl chr 8:12,101,594...12,120,592
|
|
G |
Med18 |
mediator complex subunit 18 |
decreases expression |
ISO |
Thimerosal results in decreased expression of MED18 mRNA |
CTD |
PMID:16870260 |
|
NCBI chr 5:144,663,316...144,668,652
Ensembl chr 5:144,663,252...144,668,635
|
|
G |
Med21 |
mediator complex subunit 21 |
increases expression |
ISO |
Thimerosal results in increased expression of MED21 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 4:179,560,509...179,583,811
Ensembl chr 4:179,560,579...179,567,548
|
|
G |
Med25 |
mediator complex subunit 25 |
decreases expression |
ISO |
Thimerosal results in decreased expression of MED25 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:95,359,961...95,375,827
Ensembl chr 1:95,360,284...95,375,877
|
|
G |
Medag |
mesenteric estrogen-dependent adipogenesis |
multiple interactions |
ISO |
[NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MEDAG mRNA |
CTD |
PMID:27188386 |
|
NCBI chr12:5,613,191...5,634,583
Ensembl chr12:5,613,208...5,634,767
|
|
G |
Megf6 |
multiple EGF-like-domains 6 |
decreases expression |
ISO |
Thimerosal results in decreased expression of MEGF6 mRNA |
CTD |
PMID:24675092 |
|
NCBI chr 5:164,738,272...164,839,142
Ensembl chr 5:164,738,352...164,839,139
|
|
G |
Mettl18 |
methyltransferase 18, RPL3 N3(tau)-histidine |
increases expression |
ISO |
Thimerosal results in increased expression of METTL18 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr13:76,345,888...76,348,798
Ensembl chr13:76,345,957...76,348,836
|
|
G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
decreases expression |
ISO |
Thimerosal results in decreased expression of MGMT mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:191,710,980...191,937,760
Ensembl chr 1:191,710,930...191,937,756
|
|
G |
Mia3 |
MIA SH3 domain ER export factor 3 |
increases expression |
ISO |
Thimerosal results in increased expression of MIA3 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr13:94,970,421...95,012,071
Ensembl chr13:94,970,424...95,011,972
|
|
G |
Mid1 |
midline 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of MID1 mRNA |
CTD |
PMID:24675092 |
|
NCBI chr X:24,116,674...24,491,205
Ensembl chr X:24,120,293...24,248,353
|
|
G |
Mier3 |
MIER family member 3 |
increases expression |
ISO |
Thimerosal results in increased expression of MIER3 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 2:43,287,546...43,316,422
Ensembl chr 2:43,287,916...43,316,136
|
|
G |
Mill1 |
MHC I like leukocyte 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of MICA mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:78,372,798...78,398,932
Ensembl chr 1:78,372,802...78,398,930
|
|
G |
Mis18bp1 |
MIS18 binding protein 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of MIS18BP1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 6:83,182,497...83,231,978
Ensembl chr 6:83,182,499...83,231,383
|
|
G |
Mkln1 |
muskelin 1 |
increases expression |
ISO |
Thimerosal results in increased expression of MKLN1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 4:59,815,912...60,124,047
Ensembl chr 4:60,002,464...60,123,993
|
|
G |
Mkrn3 |
makorin, ring finger protein, 3 |
decreases expression |
ISO |
Thimerosal results in decreased expression of MKRN3 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:115,926,774...115,929,288
Ensembl chr 1:115,926,776...115,929,283
|
|
G |
Mlf2 |
myeloid leukemia factor 2 |
decreases expression |
ISO |
Thimerosal results in decreased expression of MLF2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 4:157,739,651...157,744,325
Ensembl chr 4:157,728,756...157,744,317
|
|
G |
Mmp16 |
matrix metallopeptidase 16 |
affects expression |
ISO |
Thimerosal affects the expression of MMP16 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 5:31,312,280...31,556,276
Ensembl chr 5:31,312,280...31,548,388
|
|
G |
Mob1a |
MOB kinase activator 1A |
decreases expression |
ISO |
Thimerosal results in decreased expression of MOB1A mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 4:115,831,581...115,848,561
Ensembl chr 4:115,831,551...115,848,561
|
|
G |
Mpi |
mannose phosphate isomerase |
decreases expression |
ISO |
Thimerosal results in decreased expression of MPI mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 8:57,947,883...57,956,205
Ensembl chr 8:57,947,893...57,956,150
|
|
G |
Mrap2 |
melanocortin 2 receptor accessory protein 2 |
decreases expression |
ISO |
Thimerosal results in decreased expression of MRAP2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 8:88,088,293...88,144,636
Ensembl chr 8:88,088,272...88,143,886
|
|
G |
Mroh1 |
maestro heat-like repeat family member 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of MROH1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 7:108,098,708...108,172,146
Ensembl chr 7:108,102,734...108,172,146
|
|
G |
Mrpl1 |
mitochondrial ribosomal protein L1 |
increases expression |
ISO |
Thimerosal results in increased expression of MRPL1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr14:13,300,522...13,359,654
Ensembl chr14:13,300,522...13,359,721
|
|
G |
Mrpl10 |
mitochondrial ribosomal protein L10 |
decreases expression |
ISO |
Thimerosal results in decreased expression of MRPL10 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr10:82,026,031...82,034,451
Ensembl chr10:82,026,031...82,034,443
|
|
G |
Mrpl50 |
mitochondrial ribosomal protein L50 |
increases expression |
ISO |
Thimerosal results in increased expression of MRPL50 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 5:63,867,437...63,872,591
|
|
G |
Mrps2 |
mitochondrial ribosomal protein S2 |
decreases expression |
ISO |
Thimerosal results in decreased expression of MRPS2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 3:11,803,044...11,806,341
Ensembl chr 3:11,801,310...11,806,313
|
|
G |
Ms4a15 |
membrane spanning 4-domains A15 |
increases expression |
ISO |
Thimerosal results in increased expression of MS4A15 mRNA |
CTD |
PMID:24675092 |
|
NCBI chr 1:207,628,305...207,641,799
Ensembl chr 1:207,628,305...207,641,799
|
|
G |
Msn |
moesin |
decreases expression |
ISO |
Thimerosal results in decreased expression of MSN mRNA |
CTD |
PMID:27188386 |
|
NCBI chr X:60,996,043...61,064,011
Ensembl chr X:60,995,951...61,065,628
|
|
G |
Mt1 |
metallothionein 1 |
affects expression increases expression |
ISO |
Thimerosal affects the expression of MT1 mRNA Thimerosal results in increased expression of MT1 mRNA; Thimerosal results in increased expression of MT1 protein |
CTD |
PMID:19357975 PMID:19386279 |
|
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049
|
|
G |
Mt2A |
metallothionein 2A |
increases expression |
ISO |
Thimerosal results in increased expression of MT2 mRNA; Thimerosal results in increased expression of MT2 protein |
CTD |
PMID:19357975 |
|
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
|
|
G |
Mt3 |
metallothionein 3 |
increases expression |
ISO |
Thimerosal results in increased expression of MT3 mRNA |
CTD |
PMID:19357975 |
|
NCBI chr19:10,848,754...10,850,158
Ensembl chr19:10,848,755...10,850,158
|
|
G |
Mta1 |
metastasis associated 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of MTA1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 6:132,178,608...132,217,641
Ensembl chr 6:132,178,853...132,217,641
|
|
G |
Mta2 |
metastasis associated 1 family, member 2 |
decreases expression |
ISO |
Thimerosal results in decreased expression of MTA2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:205,838,181...205,846,903
Ensembl chr 1:205,837,964...205,846,946
|
|
G |
Mtarc2 |
mitochondrial amidoxime reducing component 2 |
decreases expression |
ISO |
Thimerosal results in decreased expression of MTARC2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr13:96,362,810...96,397,284
|
|
G |
Mtcl2 |
microtubule crosslinking factor 2 |
increases expression |
ISO |
Thimerosal results in increased expression of MTCL2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 3:145,669,102...145,741,578
Ensembl chr 3:145,675,443...145,740,871
|
|
G |
Mtcl3 |
MTCL family member 3 |
decreases expression |
ISO |
Thimerosal results in decreased expression of MTCL3 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:28,629,036...28,701,416
Ensembl chr 1:28,620,293...28,701,796
|
|
G |
Mtfp1 |
mitochondrial fission process 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of MTFP1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr14:78,968,434...78,972,274
Ensembl chr14:78,968,442...78,972,274
|
|
G |
Mthfd2l |
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2-like |
increases expression |
ISO |
Thimerosal results in increased expression of MTHFD2L mRNA |
CTD |
PMID:27188386 |
|
NCBI chr14:17,089,947...17,170,036
Ensembl chr14:17,089,952...17,170,112
|
|
G |
Mtpap |
mitochondrial poly(A) polymerase |
increases expression |
ISO |
Thimerosal results in increased expression of MTPAP mRNA |
CTD |
PMID:27188386 |
|
NCBI chr17:53,320,739...53,341,500
Ensembl chr17:53,320,741...53,341,538
|
|
G |
Mtr |
5-methyltetrahydrofolate-homocysteine methyltransferase |
multiple interactions decreases expression |
ISO |
Glutathione inhibits the reaction [Thimerosal inhibits the reaction [[Hydroxocobalamin co-treated with S-Adenosylmethionine] results in increased activity of MTR protein alternative form]]; Thimerosal affects the reaction [IGF1 protein results in increased activity of MTR protein]; Thimerosal inhibits the reaction [[Hydroxocobalamin co-treated with S-Adenosylmethionine] results in increased activity of MTR protein alternative form]; Thimerosal inhibits the reaction [mecobalamin results in increased activity of MTR protein alternative form] Thimerosal results in decreased expression of MTR mRNA |
CTD |
PMID:14745455 PMID:26989453 PMID:27188386 |
|
NCBI chr17:58,219,998...58,308,560
Ensembl chr17:58,220,071...58,304,822
|
|
G |
Mvb12a |
multivesicular body subunit 12A |
decreases expression |
ISO |
Thimerosal results in decreased expression of MVB12A mRNA |
CTD |
PMID:27188386 |
|
NCBI chr16:18,252,227...18,257,111
Ensembl chr16:18,252,222...18,257,539
|
|
G |
Mxd1 |
max dimerization protein 1 |
increases expression |
ISO |
Thimerosal results in increased expression of MXD1 mRNA |
CTD |
PMID:16870260 |
|
NCBI chr 4:119,097,353...119,118,080
Ensembl chr 4:119,097,353...119,117,751
|
|
G |
Mxra8 |
matrix remodeling associated 8 |
decreases expression |
ISO |
Thimerosal results in decreased expression of MXRA8 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 5:166,448,919...166,453,645
Ensembl chr 5:166,449,154...166,453,636
|
|
G |
Mynn |
myoneurin |
increases expression |
ISO |
Thimerosal results in increased expression of MYNN mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 2:112,779,654...112,797,188
Ensembl chr 2:112,779,657...112,796,397
|
|
G |
Myo1e |
myosin IE |
decreases expression |
ISO |
Thimerosal results in decreased expression of MYO1E mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 8:70,887,934...71,080,180
Ensembl chr 8:70,887,870...71,080,169
|
|
G |
Myo5a |
myosin VA |
decreases expression |
ISO |
Thimerosal results in decreased expression of MYO5A mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 8:75,811,985...75,980,049
Ensembl chr 8:75,812,412...75,975,918
|
|
G |
Myo6 |
myosin VI |
decreases expression |
ISO |
Thimerosal results in decreased expression of MYO6 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 8:81,087,157...81,242,022
Ensembl chr 8:81,087,139...81,239,292
|
|
G |
Myo9a |
myosin IXA |
increases expression |
ISO |
Thimerosal results in increased expression of MYO9A mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 8:60,149,234...60,352,330
Ensembl chr 8:60,149,234...60,350,514
|
|
G |
Mzf1 |
myeloid zinc finger 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of MZF1 mRNA |
CTD |
PMID:24675092 |
|
NCBI chr 1:73,670,522...73,682,885
Ensembl chr 1:73,670,541...73,681,635
|
|
G |
N4bp2l2 |
NEDD4 binding protein 2-like 2 |
increases expression |
ISO |
Thimerosal results in increased expression of N4BP2L2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr12:137,342...200,292
Ensembl chr12:103,590...197,784
|
|
G |
N4bp3 |
Nedd4 binding protein 3 |
decreases expression |
ISO |
Thimerosal results in decreased expression of N4BP3 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr10:35,898,031...35,906,704
Ensembl chr10:35,899,096...35,907,001
|
|
G |
Naa16 |
N(alpha)-acetyltransferase 16, NatA auxiliary subunit |
decreases expression |
ISO |
Thimerosal results in decreased expression of NAA16 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr15:54,711,620...54,770,915
Ensembl chr15:54,711,621...54,770,896
|
|
G |
Naaa |
N-acylethanolamine acid amidase |
increases expression |
ISO |
Thimerosal results in increased expression of NAAA mRNA |
CTD |
PMID:27188386 |
|
NCBI chr14:15,777,306...15,796,411
Ensembl chr14:15,777,306...15,796,410
|
|
G |
Naprt |
nicotinate phosphoribosyltransferase |
decreases expression |
ISO |
Thimerosal results in decreased expression of NAPRT mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 7:107,576,645...107,580,102
Ensembl chr 7:107,576,627...107,580,102
|
|
G |
Nasp |
nuclear autoantigenic sperm protein |
decreases expression |
ISO |
Thimerosal results in decreased expression of NASP mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 5:130,057,363...130,083,003
Ensembl chr 5:130,057,363...130,082,928
|
|
G |
Natd1 |
N-acetyltransferase domain containing 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of NATD1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr10:45,580,154...45,590,333
|
|
G |
Nav3 |
neuron navigator 3 |
increases expression |
ISO |
Thimerosal results in increased expression of NAV3 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 7:45,052,206...45,840,471
Ensembl chr 7:45,054,296...45,840,698
|
|
G |
Nbas |
NBAS subunit of NRZ tethering complex |
decreases expression |
ISO |
Thimerosal results in decreased expression of NBAS mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 6:36,048,357...36,353,206
Ensembl chr 6:36,048,191...36,352,984
|
|
G |
Ncam1 |
neural cell adhesion molecule 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of NCAM1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 8:49,865,629...50,165,687
Ensembl chr 8:49,865,633...50,166,014
|
|
G |
Ndrg1 |
N-myc downstream regulated 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of NDRG1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 7:98,684,487...98,725,869
Ensembl chr 7:98,684,487...98,725,880
|
|
G |
Ndufa5 |
NADH:ubiquinone oxidoreductase subunit A5 |
increases expression |
ISO |
Thimerosal results in increased expression of NDUFA5 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 4:52,997,327...53,005,685
Ensembl chr 4:52,995,546...53,005,598
|
|
G |
Ndufa9 |
NADH:ubiquinone oxidoreductase subunit A9 |
increases expression |
ISO |
Thimerosal results in increased expression of NDUFA9 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 4:159,659,242...159,688,034
Ensembl chr 4:159,659,242...159,688,018
|
|
G |
Ndufaf4 |
NADH:ubiquinone oxidoreductase complex assembly factor 4 |
increases expression |
ISO |
Thimerosal results in increased expression of NDUFAF4 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 5:38,605,169...38,610,341
Ensembl chr 5:38,605,153...38,610,336
|
|
G |
Ndufb7 |
NADH:ubiquinone oxidoreductase subunit B7 |
decreases expression |
ISO |
Thimerosal results in decreased expression of NDUFB7 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr19:24,568,241...24,572,579
Ensembl chr19:24,568,241...24,572,579
|
|
G |
Nefh |
neurofilament heavy chain |
decreases expression |
ISO |
Thimerosal results in decreased expression of NEFH mRNA |
CTD |
PMID:27188386 |
|
NCBI chr14:79,830,362...79,840,347
Ensembl chr14:79,830,362...79,840,351
|
|
G |
Negr1 |
neuronal growth regulator 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of NEGR1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 2:245,624,460...246,359,605
Ensembl chr 2:245,624,435...246,356,730
|
|
G |
Nes |
nestin |
decreases expression |
ISO |
Thimerosal results in decreased expression of NES mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 2:173,437,867...173,447,777
Ensembl chr 2:173,438,734...173,447,777
|
|
G |
Nf1 |
neurofibromin 1 |
affects expression |
ISO |
Thimerosal affects the expression of NF1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr10:64,306,027...64,539,112
Ensembl chr10:64,306,301...64,536,658
|
|
G |
Nfat5 |
nuclear factor of activated T-cells 5 |
decreases expression |
ISO |
Thimerosal results in decreased expression of NFAT5 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr19:35,199,737...35,286,675
Ensembl chr19:35,199,016...35,286,675
|
|
G |
Nfatc2ip |
nuclear factor of activated T-cells 2 interacting protein |
decreases expression |
ISO |
Thimerosal results in decreased expression of NFATC2IP mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:180,954,834...180,971,847
Ensembl chr 1:180,955,043...180,971,747
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
increases expression multiple interactions |
ISO |
Thimerosal results in increased expression of NFE2L2 protein Aluminum Hydroxide promotes the reaction [Thimerosal results in increased expression of NFE2L2 protein] |
CTD |
PMID:36411272 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfyb |
nuclear transcription factor Y subunit beta |
increases expression |
ISO |
Thimerosal results in increased expression of NFYB mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 7:20,964,988...20,980,569
Ensembl chr 7:20,964,993...20,980,565
|
|
G |
Ngf |
nerve growth factor |
multiple interactions decreases response to substance |
ISO |
[Thimerosal co-treated with NGF protein] results in decreased phosphorylation of NTRK1 protein NGF protein results in decreased susceptibility to Thimerosal |
CTD |
PMID:15843506 |
|
NCBI chr 2:189,901,058...189,954,452
Ensembl chr 2:189,901,058...189,954,452
|
|
G |
Nipal3 |
NIPA-like domain containing 3 |
decreases expression |
ISO |
Thimerosal results in decreased expression of NIPAL3 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 5:147,687,310...147,725,838
Ensembl chr 5:147,685,288...147,726,351
|
|
G |
Nipbl |
NIPBL, cohesin loading factor |
decreases expression |
ISO |
Thimerosal results in decreased expression of NIPBL mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 2:57,399,443...57,586,770
Ensembl chr 2:57,399,445...57,565,899
|
|
G |
Nipsnap1 |
nipsnap homolog 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of NIPSNAP1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr14:79,734,234...79,758,101
Ensembl chr14:79,734,209...79,758,098
|
|
G |
Nkain2 |
sodium/potassium transporting ATPase interacting 2 |
decreases expression |
ISO |
Thimerosal results in decreased expression of NKAIN2 mRNA |
CTD |
PMID:24675092 |
|
NCBI chr 1:24,668,627...25,877,051
Ensembl chr 1:24,669,462...25,877,064
|
|
G |
Nlrx1 |
NLR family member X1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of NLRX1 mRNA |
CTD |
PMID:24675092 |
|
NCBI chr 8:44,588,476...44,606,678
Ensembl chr 8:44,590,048...44,606,484
|
|
G |
Nme4 |
NME/NM23 nucleoside diphosphate kinase 4 |
decreases expression |
ISO |
Thimerosal results in decreased expression of NME4 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr10:15,114,624...15,118,479
Ensembl chr10:15,002,926...15,118,479
|
|
G |
Nog |
noggin |
multiple interactions decreases expression |
ISO |
[NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of APOH mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CPEB2 mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LNPEP mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAP1LC3C mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MEDAG mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PITPNM2 mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SEPSECS mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLCO4A1-AS1 mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SNCAIP mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMC5 mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ABTB3 mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CALML4 mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CAPN5 mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FLCN mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FRA10AC1 mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAOA mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of OTULINL mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PIAS2 mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLEKHF2 mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of POP1 mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SAPCD2 mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC25A21 mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC30A5 mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TTC39C mRNA Thimerosal results in decreased expression of NOG mRNA |
CTD |
PMID:27188386 |
|
NCBI chr10:74,128,712...74,130,339
Ensembl chr10:74,128,712...74,130,339
|
|
G |
Nol3 |
nucleolar protein 3 |
decreases expression |
ISO |
Thimerosal results in decreased expression of NOL3 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr19:33,154,061...33,158,250
Ensembl chr19:33,154,062...33,158,250
|
|
G |
Nop53 |
NOP53 ribosome biogenesis factor |
decreases expression |
ISO |
Thimerosal results in decreased expression of NOP53 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:76,629,084...76,636,902
Ensembl chr 1:76,629,069...76,636,902
|
|
G |
Npas3 |
neuronal PAS domain protein 3 |
increases expression |
ISO |
Thimerosal results in increased expression of NPAS3 mRNA |
CTD |
PMID:24675092 |
|
NCBI chr 6:70,702,773...71,527,928
Ensembl chr 6:70,703,170...71,524,884
|
|
G |
Npat |
nuclear protein, co-activator of histone transcription |
increases expression |
ISO |
Thimerosal results in increased expression of NPAT mRNA |
CTD |
PMID:16870260 |
|
NCBI chr 8:53,932,993...53,970,875
Ensembl chr 8:53,932,993...53,970,875
|
|
G |
Nphp1 |
nephrocystin 1 |
increases expression |
ISO |
Thimerosal results in increased expression of NPHP1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 3:114,960,650...115,016,234
Ensembl chr 3:114,960,650...115,016,234
|
|
G |
Nprl3 |
NPR3-like, GATOR1 complex subunit |
decreases expression |
ISO |
Thimerosal results in decreased expression of NPRL3 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr10:15,355,361...15,395,812
Ensembl chr10:15,355,355...15,395,810
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
increases expression |
ISO |
Thimerosal results in increased expression of NQO1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nr2c2 |
nuclear receptor subfamily 2, group C, member 2 |
decreases expression |
ISO |
Thimerosal results in decreased expression of NR2C2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 4:124,610,216...124,666,813
Ensembl chr 4:124,608,960...124,661,902
|
|
G |
Nr4a1 |
nuclear receptor subfamily 4, group A, member 1 |
increases expression |
ISO |
Thimerosal results in increased expression of NR4A1 mRNA |
CTD |
PMID:16870260 |
|
NCBI chr 7:132,368,399...132,389,300
Ensembl chr 7:132,374,840...132,389,297
|
|
G |
Nr4a2 |
nuclear receptor subfamily 4, group A, member 2 |
increases expression |
ISO |
Thimerosal results in increased expression of NR4A2 mRNA |
CTD |
PMID:16870260 |
|
NCBI chr 3:41,689,847...41,707,036
Ensembl chr 3:41,689,851...41,697,877
|
|
G |
Nrdc |
nardilysin convertase |
increases expression |
ISO |
Thimerosal results in increased expression of NRDC mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 5:123,755,807...123,818,910
Ensembl chr 5:123,755,806...123,818,595
|
|
G |
Nrm |
nurim |
decreases expression |
ISO |
Thimerosal results in decreased expression of NRM mRNA |
CTD |
PMID:27188386 |
|
NCBI chr20:2,888,321...2,892,804
Ensembl chr20:2,877,567...2,891,802
|
|
G |
Nt5dc2 |
5'-nucleotidase domain containing 2 |
decreases expression |
ISO |
Thimerosal results in decreased expression of NT5DC2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr16:6,322,485...6,330,538
Ensembl chr16:6,322,236...6,330,537
|
|
G |
Ntrk1 |
neurotrophic receptor tyrosine kinase 1 |
multiple interactions |
ISO |
[Thimerosal co-treated with NGF protein] results in decreased phosphorylation of NTRK1 protein |
CTD |
PMID:15843506 |
|
NCBI chr 2:173,236,961...173,253,806
Ensembl chr 2:173,236,963...173,253,770
|
|
G |
Ntrk3 |
neurotrophic receptor tyrosine kinase 3 |
decreases expression |
ISO |
Thimerosal results in decreased expression of NTRK3 mRNA |
CTD |
PMID:24675092 |
|
NCBI chr 1:132,116,472...132,503,849
Ensembl chr 1:132,132,849...132,503,286
|
|
G |
Nub1 |
negative regulator of ubiquitin-like proteins 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of NUB1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 4:10,442,917...10,473,689
Ensembl chr 4:10,442,917...10,473,694
|
|
G |
Nynrin |
NYN domain and retroviral integrase containing |
decreases expression |
ISO |
Thimerosal results in decreased expression of NYNRIN mRNA |
CTD |
PMID:27188386 |
|
NCBI chr15:29,332,873...29,355,215
Ensembl chr15:29,332,869...29,355,215
|
|
G |
Obi1 |
ORC ubiquitin ligase 1 |
increases expression |
ISO |
Thimerosal results in increased expression of OBI1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr15:81,269,413...81,308,734
Ensembl chr15:81,269,416...81,308,734
|
|
G |
Obsl1 |
obscurin like cytoskeletal adaptor 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of OBSL1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 9:76,967,802...76,993,771
Ensembl chr 9:76,974,253...76,993,560
|
|
G |
Ociad1 |
OCIA domain containing 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of OCIAD1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr14:34,897,851...34,915,291
Ensembl chr14:34,897,847...34,915,286
|
|
G |
Omp |
olfactory marker protein |
increases expression |
ISO |
Thimerosal results in increased expression of OMP mRNA |
CTD |
PMID:24675092 |
|
NCBI chr 1:152,440,278...152,440,828
Ensembl chr 1:152,433,652...152,441,922
|
|
G |
Osbpl8 |
oxysterol binding protein-like 8 |
decreases expression |
ISO |
Thimerosal results in decreased expression of OSBPL8 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 7:46,596,944...46,749,888
Ensembl chr 7:46,596,983...46,749,888
|
|
G |
Otub2 |
OTU deubiquitinase, ubiquitin aldehyde binding 2 |
decreases expression |
ISO |
Thimerosal results in decreased expression of OTUB2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 6:122,545,067...122,563,657
Ensembl chr 6:122,545,061...122,563,644
|
|
G |
Otud4 |
OTU deubiquitinase 4 |
decreases expression |
ISO |
Thimerosal results in decreased expression of OTUD4 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr19:28,236,713...28,279,815
Ensembl chr19:28,236,713...28,279,815
|
|
G |
Otud6b |
OTU deubiquitinase 6B |
increases expression |
ISO |
Thimerosal results in increased expression of OTUD6B mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 5:28,181,992...28,214,486
Ensembl chr 5:28,023,594...28,214,334
|
|
G |
Otulinl |
OTU deubiquitinase with linear linkage specificity like |
multiple interactions |
ISO |
[NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of OTULINL mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 2:78,405,994...78,433,860
Ensembl chr 2:78,408,593...78,433,838
|
|
G |
P4ha1 |
prolyl 4-hydroxylase subunit alpha 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of P4HA1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr20:27,302,046...27,352,098
Ensembl chr20:27,302,141...27,352,786
|
|
G |
Pacsin1 |
protein kinase C and casein kinase substrate in neurons 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of PACSIN1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr20:5,718,134...5,768,064
Ensembl chr20:5,719,857...5,765,313
|
|
G |
Paip2b |
poly(A) binding protein interacting protein 2B |
decreases expression |
ISO |
Thimerosal results in decreased expression of PAIP2B mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 4:116,292,001...116,323,387
Ensembl chr 4:116,292,020...116,323,379
|
|
G |
Pald1 |
phosphatase domain containing, paladin 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of PALD1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr20:29,269,814...29,334,850
Ensembl chr20:29,270,193...29,334,858
|
|
G |
Pank2 |
pantothenate kinase 2 |
increases expression |
ISO |
Thimerosal results in increased expression of PANK2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 3:118,483,382...118,519,551
Ensembl chr 3:118,483,444...118,518,320
|
|
G |
Pard3b |
par-3 family cell polarity regulator beta |
increases expression |
ISO |
Thimerosal results in increased expression of PARD3B mRNA |
CTD |
PMID:24675092 |
|
NCBI chr 9:63,038,435...64,067,178
Ensembl chr 9:63,038,436...64,068,053
|
|
G |
Parpbp |
PARP1 binding protein |
increases expression |
ISO |
Thimerosal results in increased expression of PARPBP mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 7:22,511,427...22,580,834
Ensembl chr 7:22,511,427...22,573,695
|
|
G |
Pc |
pyruvate carboxylase |
decreases expression |
ISO |
Thimerosal results in decreased expression of PC mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 1:201,799,374...201,898,412
Ensembl chr 1:201,804,267...201,898,380
|
|
G |
Pcbp2 |
poly(rC) binding protein 2 |
decreases expression |
ISO |
Thimerosal results in decreased expression of PCBP2 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 7:133,605,375...133,631,312
Ensembl chr 7:133,605,573...133,629,863
|
|
G |
Pcdha9 |
protocadherin alpha 9 |
increases expression |
ISO |
Thimerosal results in increased expression of PCDHA9 mRNA |
CTD |
PMID:27188386 |
|
Ensembl chr18:28,581,225...28,846,211
|
|
G |
Pclo |
piccolo (presynaptic cytomatrix protein) |
increases expression |
ISO |
Thimerosal results in increased expression of PCLO mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 4:19,691,439...20,050,015
Ensembl chr 4:19,695,315...20,049,885
|
|
G |
Pcm1 |
pericentriolar material 1 |
decreases expression |
ISO |
Thimerosal results in decreased expression of PCM1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr16:51,008,315...51,105,261
Ensembl chr16:51,008,315...51,105,091
|
|
G |
Pcnp |
PEST proteolytic signal containing nuclear protein |
decreases expression |
ISO |
Thimerosal results in decreased expression of PCNP mRNA |
CTD |
PMID:27188386 |
|
NCBI chr11:44,592,766...44,607,372
Ensembl chr11:44,592,742...44,607,348
|
|
G |
Pcnx1 |
pecanex 1 |
increases expression |
ISO |
Thimerosal results in increased expression of PCNX1 mRNA |
CTD |
PMID:27188386 |
|
NCBI chr 6:101,565,461...101,702,339
Ensembl chr 6:101,565,580...101,702,271
|
|
G |
|